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Abstract: Researchers have recently called for human lactation research to be conceptualized as
a biological framework where maternal and infant factors impacting human milk, in terms of
composition, volume and energy content are studied along with relationships to infant growth,
development and health. This approach allows for the development of evidence-based interventions
that are more likely to support breastfeeding and lactation in pursuit of global breastfeeding goals.
Here we summarize the seminal findings of our research programme using a biological systems
approach traversing breast anatomy, milk secretion, physiology of milk removal with respect to
breastfeeding and expression, milk composition and infant intake, and infant gastric emptying,
culminating in the exploration of relationships with infant growth, development of body composition,
and health. This approach has allowed the translation of the findings with respect to education, and
clinical practice. It also sets a foundation for improved study design for future investigations in
human lactation.
Keywords: lactation; breastfeeding; human milk; milk composition; breast; infant feeding
1. Introduction
Breastfeeding is a major determinant of infant short- and long-term health, preventing
acute infections and programming lower risk for chronic disease and is therefore considered
to be a major public health focus [1]. Despite the wealth of information on the benefits
to both the mother and the infant, global breastfeeding rates remain low, averaging only
41% [2]. To identify and address the issues faced by the breastfeeding dyad a foundational
knowledge of the ‘norm’ is required. In the haste to provide support and solutions, an
understanding of the basic science is frequently neglected in favour of the implementation
of interventional trials that promise advances in care but are themselves based on an
incomplete foundational understanding. The dearth of research into the fundamentals
of human lactation over the latter part of the last century, combined with the lack of
translation of the limited research actually performed into the medical model, has left
clinicians little scope and tools to objectively assess breastfeeding problems. Evidence-
based care, established from an understanding of the basic principles of lactation and
mammary gland function is imperative to improve breastfeeding rates and subsequently
the health and wellbeing of breastfeeding women, infants’, and their families.
The evolution of our research program has been in direct response to the need to
fill the translation gap and has been a journey from basic research into the anatomy,
function of the breast and milk composition to multidimensional translational research
Nutrients 2021, 13, 3071. https://doi.org/10.3390/nu13093071 https://www.mdpi.com/journal/nutrients
Nutrients 2021, 13, 3071 2 of 46
elucidating mechanisms by which breastfeeding confers a multitude of benefits. These
studies have provided the foundation for the development of successful interventions
for those mothers experiencing lactation difficulties and have informed and reassured
those women, particularly first-time mothers, that they are ‘normal’. This road has not
been smooth, with findings that have disrupted the field requiring the reassessment of
conventional dogma and change of deep-seated beliefs. Importantly, the rewards of change
have been tangible and impactful for mothers and their babies. This review traces the main
focal points of our research programme over the last 25 years and takes a biological systems
approach by tracking breast milk from the mother (the breast) to the infant (Figure 1) [3]
and aims to highlight and document these findings in the broader context of mammary
gland function and the breastfeeding dyad, in order to provide a holistic platform of
knowledge from which others may continue to work from in their pursuit to define better
health outcomes for the next generation [4].
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Figure 1. An overview of the structure of the review of our research programme from a biological 
systems perspective. 
2. Breast Anatomy 
Despite the breast being the sole source of nutrition for the infant, this organ is rarely 
studied in its functional state. Interestingly, one of the most thorough investigations 
comes from over 180 years ago, by renowned anatomist and surgeon Sir Astley Cooper. 
This work, published in 1840, is a remarkable description of the anatomy of the lactating 
human breast and was performed in response to a request to document diseases of the 
breast. Cooper asserted that knowledge of basic anatomy was critical to the understand-
ing of breast anomalies and disease. As such, he proceeded to meticulously investigate 
the anatomy of the breast, sourcing breasts for dissection from the corpses of women who 
had died during lactation. For over 150 years, Cooper’s work was the most complete ex-
amination of the lactating breast with his work most notable for its depictions of the ductal 
structures of the breast, obtained by the delicate dissection of the mammary ductal system 
after the injection of coloured wax into the ducts of the nipple [5] (Figure 2). His contribu-
tion is memorialised via the eponymously named Cooper’s ligaments that provide a 
framework for the tissues of the breast. 
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2. Breast Anatomy
Despite the breast being the sole source of nutrition for the infant, this organ is rarely
studied in its functional state. Interestingly, one of the most thorough investigations comes
from over 180 years ago, by renowned anatomist and surgeon Sir Astley Cooper. This work,
published in 1840, is a remarkable description of the anatomy of the lactating human breast
and was performed in response to a request to document diseases of the breast. Cooper
asserted that knowledge of basic anatomy was critical to the understanding of breast
anomalies and disease. As such, he proce ded to meticul usly investigate the anatomy
of the breast, sourcing breasts for dis ction from the corps s of w men who had died
during lactation. For ov r 150 years, Coop r’s work wa the most complete examination of
the lactating breast with his work most notable for its depictions of the ductal structures
of the breast, obtained by the delicate dissection of the mammary ductal system after the
injection of coloured wax into the ducts of the nipple [5] (Figure 2). His contribution is
memorialised via the eponymously named Cooper’s ligaments that provide a framework
for the tissues of the breast.
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Figure 2. Sir Astley Cooper’s illustrations of the ductal system of the lactating breast. Duct were 
injected with coloured wax prior to dissection [6]. 
The macro-anatomy of the lactating breast may be described by its external and in-
ternal components. The external structures: skin, areola, Montgomery tubercles and nip-
ple exhibit wide variation in size and colour amongst women. Internally the main tissues 
of the breast consist of the glandular-ductal system, adipose tissue and extracellular ma-
trix supported by the fibrous Cooper’s ligaments. Like the external structures, the internal 
structures of the breast are also variable between women in terms of volume of tissues. At 
the cellular level, the glandular-ductal system consists of hundreds of alveoli, each com-
prised of a bilayer of luminal and basal cells. The luminal cells consist of mammary epi-
thelial cells or lactocytes that serve to synthesise and secrete milk into the lumen of the 
alveolus. The alveoli are surrounded by a network of myoepithelial cells that contract at 
milk ejection (ME), to expel the milk from the alveoli into the milk ducts, thus making it 
available to the infant. 
As originally depicted by Cooper, the ductal structures within the breast are ar-
ranged in a complex network. Each alveolus is connected to this network via a ductal 
outlet and the diameters of these lactiferous ducts progressively increase in size as they 
get closer to the nipple where they narrow once more as they pass through the nipple, 
therefore providing a mechanism to prevent the escape of milk. A key aspect of Cooper’s 
work was the presence of lactiferous sinuses, ducts distended with milk just beneath the 
areolae. According to Cooper, the areola was considered an extension of the nipple and 
had three main functions: to give a greater adhesion to the infant’s lips; add to the sensi-
bility and connectivity of the areola with mammary gland; and an area embraced by the 
infant’s lips and into infant’s mouth from where the lactiferous sinuses behind the areola 
can be emptied by the pressure of the lips of the infant [5]. In other words, it was believed 
that milk transfer to the infant was executed by the lips of the infant when applying a 
compressive pressure around the areola. This observation highlighted Cooper’s assertion 
that knowledge of the anatomy of the mammary gland was important for understanding 
function and formed the basis of milk removal theory for over a century. 
The contribution of advanced imaging techniques such as the non-invasive approach 
of ultrasonography built upon the remarkable work performed by Cooper and has, at the 
same time, updated some of the interpretations of the previous model, leading to our cur-
rent understanding of breast anatomy [7] and has impacted the clinical appraisal of milk 
removal. Ramsay et al. used ultrasound to image both breasts to determine the number of 
main ducts, duct morphology and distribution of glandular and adipose tissue. Milk 
ducts, observed in a resting state, were identified at the base of the nipple and were su-
perficial and easily compressible lending support to anecdotal reports of tight bras or seat 
belts blocking ducts and causing milk stasis [8]. The average number of ducts exiting the 
nipple was nine with a range from as few as four to as many as 18, less than the 20–25 
typically stated and consistent with observed milk jets during pumping [9]. Resting milk 
duct diameters are small (2 mm, range 1.0–4.4 mm) and similar in size to non-lactating 
duct diameters except for the significant dilation observed at ME. The lower number and 
Figure 2. Sir Astley Cooper’s illustrations of the ductal system of the lactating breast. Duct were
injected with coloured wax prior to dissection [6].
The acro-anato y of the lactating breast may be described by its external and
internal components. The external structures: skin, areola, Montgomery tubercles and
nipple exhibit wide variation in size and colour amongst women. Internally the main
tissues of the breast consist of the glandular-ductal system, adipose tissue and extracellular
matrix supported by the fibrous Cooper’s ligaments. Like the external structures, the
internal struc ures of the breast are lso variable betw en women in terms of volume of
tissues. At th c llular level, the glandular-ductal sy em consists of hundreds of alve li,
each comprised of a bilayer of luminal and basal cells. The luminal ell consist of mammary
epithe ial cells or lactocytes that serve to synthesise and secrete l en of the
alveolus. The alveoli are sur ounded by a network of myoepithelial cel s that contract at
ilk ejection ( E), to expel the milk from the alveoli into the milk ducts, thus making it
available to the infant.
As originally depicted by Cooper, the ductal s ructures within the breast ar arr nged
in a complex network. Each alveolus is connected to this network via a ductal outlet nd the
diameters of these lactiferous ducts progressively increase in size as th y get clos r to t e
nipple where they narrow once more as they pass through the nipple, therefore providing a
mechanism to prevent the escape of milk. A key aspect of Cooper’s work was the presence
of lactiferous sinuses, ducts distended with milk just beneath the areolae. According to
Cooper, the areola was considered an extension of the nipple and had three main functions:
to give a greater adhesion to the infant’s lips; add to the sensibility and connectivity of the
areola with mammary gland; and an area embraced by the infant’s lips and into infant’s
mouth from where the lactiferous sinuses behind the areola can be emptied by the pressure
of the lips of the infant [5]. In other words, it was believed that milk transfer to the infant
was executed by the lips of the infant when applying a compressive pressure around the
areola. This observation highlighted Cooper’s assertion that knowledge of the anatomy of
the mammary gland was important for understanding function and formed the basis of
milk removal theory for over a century.
The contribution of advanced imaging techniques such as the non-invasive approach
of ultrasonography built upon the remarkable work performed by Cooper and has, at
the same time, updated some of the interpretations of the previous model, leading to our
current understanding of breast anatomy [7] and has impacted the clinical appraisal of milk
removal. Ramsay et al. used ultrasound to image both breasts to determine the number of
main ducts, duct morphology and distribution of glandular and adipose tissue. Milk ducts,
observed in a resting state, were identified at the base of the nipple and were superficial and
easily compressible lending support to anecdotal reports of tight bras or seat belts blocking
ducts and causing milk stasis [8]. The average number of ducts exiting the nipple was nine
with a range from as few as four to as many as 18, less than the 20–25 typically stated and
consistent with observed milk jets during pumping [9]. Resting milk duct diameters are
small (2 mm, range 1.0–4.4 mm) and similar in size to non-lactating duct diameters except
for the significant dilation observed at ME. The lower number and smaller diameters of
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the ducts compared to Cooper’s work suggests that for some women who exhibit poor
lactation outcomes after surgical procedures, it is the severing of the majority of ducts that
that is contributing to low supply issues. Importantly, neither the number of the ducts nor
the mean diameter of the ducts were related to nipple diameter providing evidence that
the internal breast morphology is not predicted by the external anatomy of the breast [7].
During pregnancy there is an increase in size, length and elasticity of the nipple
which varies widely between women [10] with reported nipple diameters of 15.7 ± 1.8 mm
and 15.8 ± 2.8 mm for the left and right nipples respectively [11]. As the infant’s mouth
accommodates the nipple, the size and shape of the nipple are clinically important for the
infant to attach adequately to the breast.
Importantly, Ramsay’s study highlighted the absence of lactiferous sinuses superficial
to the areolae, a result in contrast to Cooper’s observations but one that was subsequently
confirmed by Gooding et al. with three-dimensional ultrasound imaging [12]. Further-
more and again in contrast to Cooper‘s reports, which have underpinned the long-held
understanding of breast anatomy and breastfeeding physiology, all of the observed ducts
branched from the areola, under the nipple and only very small volumes of milk (1–10 mL)
could be expressed from them in the absence of ME, suggesting the function of the ducts is
to transport rather than store milk. Cooper’s injection of coloured wax/glue through the
nipple ductal outlets combined with our observation that the ducts are extremely elastic
likely provided for an expanded wax representation of the ductal system leading to the
erroneous depiction of lactiferous sinuses and an overestimation of the volume of milk that
would be stored under the areola. These findings explain the variation in volumes of milk
removed both in the colostral phase where the milk volume is low and viscous (Figure 3)
and prior to milk ejection in established lactation.
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As mentioned previously, internally the breast consists primarily of glandular and 
adipose tissue, with some connective tissue as well as the myoepithelial (smooth muscle) 
network surrounding the alveoli. The proportions of glandular and adipose tissue were 
found to be in an approximate ratio of 2:1 and was similar within women. However, there 
is wide variation between women for glandular tissue 65 ± 11% (45–83%) and 63 ± 9% (46–
83%), and adipose tissue (37 ± 9% (16–51%) and 35 ± 12% (9–54%) for right and left breasts 
respectively). Interestingly, 24 h milk production was not correlated with the amount of 
glandular tissue, number of milk ducts, duct diameters or storage capacity of the breast. 
Given that storage capacity is a reflection of the amount of glandular tissue, the finding 
that some breasts are comprised of up to 50% adipose tissue suggests that it is possible 
that some larger breasts may actually have a lower storage capacity than otherwise ex-
pected and may account for the unexpected frequent feeding observed in these dyads. In 
total, these findings reaffirm the evidence that for physiologically normal breastfeeding 
women, milk production is driven by the interplay of the infant’s appetite, frequency and 
Figure 3. e understanding of the anatomy of the lactating breast. (a) Coopers ligaments (b) super-
ficial and retromammary fat layers (c) milk duct system (d) macro anatomy of the breast. © Medela
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s entioned previously, internally the breast consists primarily of glandular and
adipose tissue, ith so e connective tissue as ell as the yoepithelial (s ooth uscle)
net r s rro i t e alveoli. e proporti s of glandular and adipose tissue were
found to be i roxi ate ratio of 2:1 s si ilar it i en. e er, there
is i i ti t o en for glandular tissue 65 ± 11% (45–83%) and 63 ± 9%
(46–83%), nd adipose tissue (37 ± 9% (16–51%) and 35 ± 12% (9–54%) for right and
left breasts respectively). Interestingly, 24 h milk production was not correlat d with the
amount of glandular tissue, number of milk ducts, duct diameters or storage capacity of
the breast. Given that storage capacity is a refl ction of the amount of glandular tissue,
t e finding th t som breasts are comprised of up to 50% adipose ti sue suggests that
i is p ssib e that some larger breasts m y actually have a lower s orage capacity than
otherwise expected and may account for the unexpect frequent feeding observed in
these dyads. I total, these findings reaffirm the evidence that for physiologically normal
breastfeeding w men, milk p oduction is driven by the interplay of the infant’s appetite,
frequency and efficacy of milk removal, and maternal anatomy. This seminal work has
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redefined our understanding of breast anatomy in lactation, thus impacting our knowledge
of breastfeeding physiology and management of breastfeeding problems.
Breast Anatomy
Number of ductal openings on the nipple is 4–18 (previously 15–20)
Milk ducts branch close to the nipple
The conventionally described lactiferous sinuses do not exist
Milk ducts can reside close to the skin surface and are easily compressible
Most of the glandular tissue is found within 30 mm of the nipple
3. Milk Ejection
The ME reflex is highly conserved across all mammalian species from monotremes
and marsupials to the placental mammals [13]. In women it is critical to the success of
lactation as little to no milk can be removed from the breast prior to ME, thus milk synthesis
is downregulated in the absence of ME.
The ME reflex is a neuroendocrine reflex is triggered by nipple stimulation sending
neural impulses to the hypothalamus stimulating the release of oxytocin from the posterior
pituitary gland into the maternal bloodstream. Oxytocin then travels via the maternal
circulation to the mammary gland, causing the contraction of the myoepithelial cells
surrounding the alveoli [14] forcing milk through the ductal system towards the nipple for
removal by the infant or a breast pump [15]. The force of the milk flow dilates the ducts
and increases positive pressure within the ducts [16–19]. This reflex, occurs within 60 s and
90 s for breastfeeding and pumping respectively [17,20] in both breasts simultaneously [21],
with slight discrepancies due to binding of oxytocin to fuller alveoli [22]. Milk ejection
is transient lasting 45 s to 3.5 min [17,23] with multiple MEs measured during a feed or
pumping session (breastfeeding: 2.5; breast pumping: 4.4) [18,24].
Employing measurement of ME with ultrasound imaging (Figure 4) or measurement
of milk flow rates [8,18,21] we have shown that while ME is individualised it is highly
conserved within women [25] such that ME patterns remain consistent between breasts,
between breastfeeding and pumping, with different pumping patterns, between weeks
and across lactation (9 months) [26]. Thus, it appears that differences in the source of
stimulation of the breast/nipple in women in established lactation does not alter the ME
reflex. Replication of the ME patterns in subsequent lactations has also been observed, [27]
building on the hypothesis that ME is innate. This finding also suggests that it is the
requirement of the infant to adapt to the mother’s ME pattern and changing rates of milk
flow in order to remove milk effectively and efficiently from the breast [28]. The volume of
milk removed by the infant is likely then governed not only by infant appetite but also by
the combination of the volume of milk stored in the breast and its availability as a result of
the ME pattern, as an increasing number of MEs during a breastfeed is related to higher
volume of milk consumed [15].




Figure 4. Ultrasound images of milk ducts pre-milk ejection (a) and post-milk ejection (b). Milk 
ducts are imaged as black (anechoic). Post milk ejection the ducts are expanded with breast milk 
(Geddes et al., unpublished). 
In relation to milk removal during pumping, the majority is removed during the first 
two MEs (76–86%) [29] emphasising that the switch from ‘stimulation’ mode to ‘expres-
sion’ mode should be made as soon as ME occurs to maximise the removal of milk early 
in the expression when intraductal pressure is at its highest [16]. Further, when the ex-
pression pattern was changed mid pumping, it did not always coincide with a ME sug-
gesting the change of pumping stimulus does not necessarily increase the likelihood of 
precipitating a ME [30]. 
To date we have utilised ultrasound imaging and milk flow measurement [16,26,31] 
as well as having explored alternative technologies such as bioimpedance spectroscopy 
and thermal imaging [31,32] for the detection of ME. Bioimpedance applied to the 
pumped breast detected the initial ME 90% of the time [23]. Temperature however was 
not successful as we were unable to detect a change in nipple temperature on the non-
pumped breast during breastfeeding or pumping, [33] despite the hypothesis that the re-
lease of oxytocin would result in a change of nipple temperature. It will be important to 
further pursue these detection technologies as development of methods to identify and 
assess ME may provide breastfeeding mothers and clinicians with biofeedback on ME 
function as well as supporting the development of breast milk expression innovations. 
Milk ejection 
Milk ejection is critical for milk removal 
Milk ejection patterns are unique to the individual 
Milk ejection patterns do not change with stimulus (breastfeeding or pumping or 
different pumping patterns) 
Milk ejection patterns do not change over lactation 
Milk ejection patterns do not change between lactations 
4. Secretory Activation 
Secretory activation (SA) marks the beginning of copious milk production and occurs 
within 48–72 h after birth commensurate with the rapid decline in progesterone after the 
delivery of the placenta [34]. The sensation of breast fullness lags the biochemical changes 
associated with SA by up to 30 h [35]. The most marked changes in milk composition at 
SA are the decreases in milk sodium and protein concentrations accompanied by the in-
creases in lactose and citrate concentrations [34]. These changes are due to both closure of 
tight junctions between lactocytes (sodium) as well as increased milk synthesis (lactose, 
protein, citrate) [35]. Delayed SA, i.e., beyond 72 h, has been associated with suboptimal 
lactation outcomes such as lower milk production and reduced duration of breastfeeding. 
While long labours, caesarean section, and obesity have been associated with delayed SA 
[36,37] we found no evidence of delayed SA in women delivering by vaginal or caesarean 
section nor with analgesic administration during caesarean births [38]. Similarly, Cregan 
i r ltrasound i ages f il t
cts r i . ost ilk j cti t e ts i
( eddes et al., unpublished).
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In relation to milk removal during pumping, the majority is removed during the first
two MEs (76–86%) [29] emphasising that the switch from ‘stimulation’ mode to ‘expression’
mode should be made as soon as ME occurs to maximise the removal of milk early in the
expression when intraductal pressure is at its highest [16]. Further, when the expression
pattern was changed mid pumping, it did not always coincide with a ME suggesting the
change of pumping stimulus does not necessarily increase the likelihood of precipitating a
ME [30].
To date we have utilised ultrasound imaging and milk flow measurement [16,26,31]
as well as having explored alternative technologies such as bioimpedance spectroscopy
and thermal imaging [31,32] for the detection of ME. Bioimpedance applied to the pumped
breast detected the initial ME 90% of the time [23]. Temperature however was not successful
as we were unable to detect a change in nipple temperature on the non-pumped breast
during breastfeeding or pumping, [33] despite the hypothesis that the release of oxytocin
would result in a change of nipple temperature. It will be important to further pursue
these detection technologies as development of methods to identify and assess ME may
provide breastfeeding mothers and clinicians with biofeedback on ME function as well as
supporting the development of breast milk expression innovations.
Milk ejection
Milk ejection is critical for milk removal
Milk ejection patterns are unique to the individual
Milk ejection patterns do not change with stimulus (breastfeeding or pumping or different
pumping patterns)
Milk ejection patterns do not change over lactation
Milk ejection patterns do not change between lactations
4. Secretory Activation
Secretory activation (SA) marks the beginning of copious milk production and occurs
within 48–72 h after birth commensurate with the rapid decline in progesterone after the
delivery of the placenta [34]. The sensation of breast fullness lags the biochemical changes
associated with SA by up to 30 h [35]. The most marked changes in milk composition at SA
are the decreases in milk sodium and protein concentrations accompanied by the increases
in lactose and citrate concentrations [34]. These changes are due to both closure of tight
junctions between lactocytes (sodium) as well as increased milk synthesis (lactose, protein,
citrate) [35]. Delayed SA, i.e., beyond 72 h, has been associated with suboptimal lactation
outcomes such as lower milk production and reduced duration of breastfeeding. While
long labours, caesarean section, and obesity have been associated with delayed SA [36,37]
we found no evidence of delayed SA in women delivering by vaginal or caesarean section
nor with analgesic administration during caesarean births [38]. Similarly, Cregan et al.
found no difference in concentration of milk citrate, lactose, protein, and sodium from
mothers of term and preterm infants [39]. However, there was greater variation in these
markers for preterm mothers and milk production was related to how many markers were
in the normal range by Day 5 [39] in that women with fewer markers in the normal range
had the lowest milk productions. The significance of these data are that previously SA
was considered a discrete event with failed SA attributed to either hormonal causes, e.g.,
no drop in progesterone due to retained placenta, or glandular causes, e.g., insufficient
mammary tissue [40]. The observation by Cregan et al., that mothers can have some
markers in the normal range and others not, indicated for the first time that the concept of a
compromised SA was possible. Hoban et al. have extended this work to daily sampling for
14 days post-partum for mothers delivering preterm and found that 40% of the samples had
normal concentrations of SA biomarkers with only a third of women reaching adequate
milk volume by day 14 [41,42]. Interestingly, sodium appeared to most predictive of low
milk volumes [42]. In this connection, small ion-selective probes are readily available to
measure sodium in milk and have been validated against bench biochemical methods
providing the potential for a point-of-care instrument [43] to monitor the initiation of
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lactation. This ability to measure markers early in lactation provides the clinician an
opportunity to increase support and care of those mothers with known risk factors to
maximise their likelihood of successfully establishing a milk production.
Early initiation of breastfeeding and/or pumping has been shown to reduce delayed
SA in at risk mothers [44]. In addition, for women pumping their milk in the first 3 days
after term and preterm birth, the application of an initiation pattern modelled on the
sucking characteristics of a term infant has been shown to improve milk production [45,46].
These findings all underscore the importance of frequent and efficient milk removal (feeding
or pumping when separated from the infant) in the first days after birth to establish a
robust milk production to meet the needs of the infant [42,46,47].
Secretory activation is marked by
• Closure of tight junctions between the lactocytes
• Biochemical changes in milk at 48–72 h
• Sensations of fullness of the breast (later than biochemical changes)
Secretory activation
• Is often delayed in at risk mothers
• Is facilitated with frequent and efficient milk removal in the early post-partum which
increases milk production
5. Milk Production
Whilst the growth, health and development of the breastfed infant depends upon an
adequate milk production it is rarely measured in both the research and clinical setting
despite clinician estimates of milk transfer being shown to be inaccurate [48] and perceived
low milk supply being a major cause of early weaning [47]. Indeed, we have found that
perceived insufficient milk supply accounts for close to half (44%) of the women attending a
tertiary hospital breastfeeding centre for advice. For these mothers, the major concern was
that the infant did not seem satisfied after a breastfeed. This perception of an insufficient
milk supply improved in a small subset of mothers who were surveyed after receiving
targeted lactation advice despite lack of confirmation of increased milk production [49].
Three methods are available to measure milk production: deuterium dilution [50,51],
test weighing [52] and hourly pumping [53,54], with all methods having advantages and
disadvantages. Deuterium dilution does not provide information about breastfeeding
patterns and has a long analysis time and requires specialist equipment, precluding its use
as a routine clinical tool. However, test weighing allows investigation of breastfeeding
patterns as well as the effectiveness of milk removal by the infant with instantaneous
results. The hourly pumping technique offers an alternative in cases where a mother is not
able to carry out test weighing but requires the infant to be fed expressed milk [53,55] and
still needs more formal validation before it can be considered for routine use [54]. As such,
24 h test weighing has underpinned many of the research studies in our laboratory.
After birth frequent and effective milk removal is critical to the establishment and
maintenance of milk production [56,57], with milk production established by week 1 to
2 [58] and production at week 2 being indicative of production at 6 weeks [59]. In a
landmark paper by Kent et al. normal breastfeeding patterns and total fat intake were
documented for mothers exclusively breastfeeding infantsbetween one and six months of
lactation and showed a wide variation of milk productions while still providing adequate
milk and fat intakes (Table 1, Figure 5) [60]. The results suggest that for this population
of mother, advice should not be given to schedule breastfeeding or to shorten or prolong
feeds and that prioritizing so call ‘hind milk’ over ‘fore milk’ is unfounded. Interestingly,
it was shown that night feedings (10 p.m.–4 a.m.) were common, with 100% of infants
under 9 weeks of age feeding at night. Furthermore, those infants consumed a significant
portion of their 24 h intake (20%) during this night feed timeframe, highlighting caution
when considering ‘sleep training’ as this could impact not only milk intake but also down
regulate milk production. This work was extended to show that milk production did
not change significantly over the first 6 months of lactation in exclusively breastfeeding
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women [61] indicating that recommendations to increase milk intake and energy intake
according to the infant’s age is not appropriate for fully breastfed infants. Intriguingly,
several studies have shown one breast is often more productive than the other with that
breast often the right breast [60,62–64] whilst others have found no difference between the
breasts [65]. Given these differences in milk production/milk intake from each breast, it is
important that the calculation of infant intake of any milk component should be made for
each breast separately [63,65].
Table 1. Breastfeeding characteristics measured for 71 exclusively breastfeeding dyads in Western
Australia, term infants 1 to 6 months old. Single breastfeed: breastfeed from one breast, breastfeeding
session: breastfeed from more than 1 breast.
Mean (SD) Range
24 h milk intake 788 (169) 478–1356
Single breastfeed
Frequency (feeds/24 h) 11 (3) 6–18
Volume transferred (mL) 76 (13) 0–240
Breastfeeding session
Frequency (feeds/24 h) 8 (2) 4–13
Total volume transferred (mL) 101 (16) 0–350
Fat content
Mean fat content (g/L) 41.1 (7.8) 22.3–61.6
Total fat consumed (g) 32.0 (7.7) 5.4–49.5
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Whilst these data documented the ‘norm’, the 24 h test weighing method was used at a
tertiary hospital breastfeeding centre for mothers with breastfeeding problems to determine
the proportion of mothers who actually had low milk production (defined as less than
440 mL/day). It was found that 46% of mothers had low production between days 6 and
13 and 45% of mothers had a low milk production between days 14–28 respectively [58].
When viewed in light of the previously mentioned 44% of mothers with a perception of low
milk supply, it shows the importance of being able to accurately assess milk production in
these women as often their perceptions can be well founded. However, test weighing is
often met with resistance because of the notion that maternal confidence will be negatively
impacted. The results of a survey of 203 women dispelled this idea, in that 66% of women
were still confident and 11% improved their confidence in breastfeeding after completing
a 24 h production measurement. Importantly, those that lost confidence all had milk
productions well below 478 mL/24 h (minimum documented milk production in Kent
et al., 2006 [60]) suggesting that this method can be used routinely by clinicians to instigate
clinical intervention when necessary [66] and without fear of negatively impacting maternal
confidence. This is aptly demonstrated in a case-study of a breastfeeding baby with Down’s
Syndrome where due to initial concerns in hospital the infant was supplemented with
formula and expressed milk in but returned home exclusively breastfeeding. Maternal
concerns about milk production were confirmed with 546 mL/24 h at 4 weeks and this
improved with additional expressions to 819 mL/24 h at 10 weeks. The increase in milk
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intake was reflected in adherences to the appropriate growth trajectory. By 24 weeks this
mother was fully breastfeeding 924 mL/24 h [67]. Further, we have found that women who
have perceived insufficient milk supply and received clinical lactation support generally
had improvement in their perceptions. However, infant unsettledness after a feed and
formula supplementation was still prevalent indicating that measures of milk production
may be useful in determining patterns of milk removal [49].
Many factors are believed to impact milk production such as age, parity, and infant
sex. Recent studies have shown no reduction of milk production with increasing maternal
age with those between 15 and 37 years and [68] those between 23 and 42 years having an
average milk production of 750 to 800 mL [69]. Similarly, there is no strong evidence yet of
an increased milk production in women with higher parity, despite the demonstration in an
animal model of epigenetic memory in mammary epithelial cells in subsequent lactations
resulting in a more robust onset of lactation and volume [70]. It is recognised however,
that infant sex appears to influence milk production in that boys on average consume
80–100 mL more than girls and this is also reflected in the storage capacity of the breast
being greater for mothers of boys [60].
6. Breast Anatomy and Milk Production
Breast hypoplasia (unilateral or bilateral) [71] impacts up to 25% or women [72] and
typically results in under or disorganised breast development resulting in limited milk
supply despite efforts to increase frequency of feeding and expression. Whilst hypoplasia
is linked to genetic causes, such as zinc transporter mutations [72] there are currently no
tests, genetic or otherwise to confirm hypoplasia and its link to low milk production.
The storage capacity of the breast is highly variable between women ranging from
74 to 382 mL (mean around 180 mL) [60]. The more milk available to the infant in the
breast the greater the volume the infant tends to receive thus women with smaller storage
capacities may need to feed more frequently than those with higher storage capacities. In
cases of very high frequency of feeding measurement of 24-h milk production would be
warranted.
Low production is also documented with women that have had breast surgery, trauma,
or nipple piercing. These procedures often sever milk ducts, thus disrupting milk removal
and, over time, potentially isolating glandular tissue, causing milk stasis and ultimately
apoptosis and regression of the tissue. Alternatively, in some instances breast implants
may have been inserted into breasts that were already hypoplastic [73–76].
7. Breast Physiology
Typically, breast growth is obvious in pregnancy due to proliferation of glandular
tissue and the differentiation lactocytes to produce milk [10,77]. Breast size however is
not indicative of milk production although women with smaller breasts are more likely to
have smaller storage capacities and therefore feed more frequently than those women with
larger breasts [77].
Increasing evidence also suggests that pregnancy complications such as gestational
diabetes mellitus, preeclampsia, gestational hypertension [78], and fetal growth restric-
tion [79] are associated with shorter durations of breastfeeding. While caesarean section
has been associated with delayed initiation of breastfeeding, in those women that breast-
feed secretory activation [38] and any breastfeeding at 6 months appears to not differ
between caesarean section and vaginal delivery [80]. In addition, women experiencing
postpartum haemorrhage, including those that receive a blood transfusion in hospital,
also show reduced breastfeeding at discharge, irrespective of haemoglobin concentration
pre-transfusion and persistence of anaemia post transfusion [81,82].
Mastitis or inflammatory lactating breast conditions often result in increased per-
meability of the alveolus, evidenced by increased human milk (HM) sodium, chloride,
lactoferrin, serum albumin concentrations and decreased HM lactose and glucose as well as
increased 24-h excretion of lactose, blood, and milk C-reactive protein [83–85]. Furthermore,
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we have observed greater numbers of immune cells and expression of immune proteins
such as granzyme B [86] in the milk of women with mastitis. Many of the changes in
milk composition seen with mastitis are observed with perceived and measured low milk
supply supporting maternal reports of reduced milk supply with mastitic episodes [83].
Blocked ducts are also commonly experienced during lactation and can be associated
with engorgement and inflammatory symptoms [87], yet little is understood about the
causes and effective treatments [88]. Whilst a blocked duct may resolve in 24 h with
increased milk removal and massage, non-resolution of these breast masses should cause
concern and initiate imaging investigations such as ultrasound to exclude other causes
such as fibroadenomas, cysts, lymph nodes and malignancy [89].
8. Medications
Few medications have been shown to impact milk production either positively or
negatively Pseudoephedrine hydrochloride a common over-the-counter decongestant
medication, was found to reduce milk production by up to 24%, due to a potential reduction
in maternal serum prolactin levels [90]. Conversely a pharmaceutical galactagogue such as
domperidone, which increases prolactin, can provide a modest increase in milk production
of on average 100 mL, in a dose dependent manner [91]. Although it is not clear whether
this increase in milk volume is confounded by the increased emptying of the breast [92].
Indeed large increases in milk production by domperidone, may not be achievable during
established lactation, due to the absence of a relationship between prolactin and short-term
rates of milk synthesis [64]
9. Factors Impacting Milk Removal
Frequent, effective milk removal from the breast is the mainstay for the establishment
and maintenance of milk production. For the breastfeeding dyad a feeding frequency
of at least 7 × 24 h in the first 2 weeks after birth is associated with establishment of an
adequate milk production [57,93] while in established lactation breastfeeding frequency
is 11 breastfeeds or 8 breastfeeding sessions [60]. While ‘normal’ feeding frequency has
been characterised there are few methods by which to gauge efficacy of milk removal. The
volume of milk removed from the breast is not indicative of effectiveness of emptying
because it does not consider the amount of milk stored in the breast, or ‘degree of breast
fullness’ and this varies significantly over a 24 h period within and between women. A
more accurate estimation is the percentage of available milk removed (PAMR) from the
breast which; is estimated from the breast storage capacity and degree of fullness of the
breast before the feeding/expression [94]. On average the term infant removes 67% of
the available milk during a breastfeed whereas expression with a hospital grade electric
breast pump removes on average 55–75% [95–98]. Data for the effectiveness of personal use
pumps and hand expression are not available, although evidence suggests that significantly
higher milk volumes are expressed with a hospital grade pump when compared to hand
expression [99].
Many factors potentially impact milk production (Table 2) for example mother and
infant separation in hospital restricts access to the breast for the infant to breastfeed,
decreases skin-to-skin contact and reduces breastfeeding [100]. Indeed, in the recent COVID
pandemic women with COVID-19 were separated from their infants initially until it was
realised that vertical transmission of the virus through milk did not occur [101]. In cases of
separation, it is critical that the mother continues to effectively remove milk from the breast
either by hand expression or by using a pump to establish milk production as reduced
feeding in the first 2 weeks has also been associated with lower milk production [59].
The mothers of preterm infants often experience a quadrupled burden with a pregnancy
complication (e.g., pre-eclampsia), disrupted development of the breast, separation from
their infant, and inability of the infant to remove large volumes of milk from the breast
thus rely expression of milk to establish and maintain their milk supply. For exclusively
pumping women, so often the situation for mothers of preterm infants, there is limited
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information on the frequency of milk removal required to maintain an adequate production.
Our study of exclusively pumping preterm mothers indicates that extension of pumping
intervals slows the rate of milk synthesis such that the synthetic rate was significantly
slower beyond 7 h. In this connection, the amount of milk removed at each pumping
episode increased from 2 to 6 h intervals, reaching a plateau at 7 h. Further, while it appears
that a minimum of 5 expressions/24 h is necessary to maintain milk production, increased
frequency is warranted for those that have not established a full production given the high
observed inter-individual variation [102].
The frequency and effectiveness of feeding at the breast can also be hampered by
several intra-oral anomalies. Our studies have shown that some infants with ankyloglossia
(tongue tie) are able to sustain an adequate milk production when breastfeeding [103]
whereas, others are unable to [104,105]. In this regard, frenotomy for an anterior tongue
tie has been shown to improve production, albeit in a small number of babies [104]. More
recently cases of tongue tie have appeared with increased frequency, most likely driven
by the increased diagnosis of posterior tongue tie. However, the subsequent increase in
frenotomy [106] have raised concerns about increased post-surgical complications [107].
Furthermore, preliminary evidence suggests that milk production can remain compromised
in a number of infants after frenotomy for posterior tongue tie, indicating other potential
causes of insufficient supply [108]. These studies have provided the impetus for revision
of the anatomy of the lingual frenulum [109–111], definitions and clinical protocols for
ankyloglossia [112], and attempts with non-surgical methods to improve breastfeeding in
infants diagnosed with ankyloglossia [113].
There are other infant anomalies that typically affect the infant’s ability to gener-
ate sufficient vacuum, which we have shown to be instrumental for effective milk re-
moval [114]. Typically, infants that have difficulty creating vacuum such as those born
preterm, infants with low tone, Down’s syndrome, and cleft lip/plate have reduced milk
removal [69,115,116]. In contrast, those infants of mothers experiencing pain during breast-
feeding often apply very strong vacuums (Baseline vacuum: control: −52 mmHg, Pain:
−95 mmHg; Peak vacuum: control: −171 mmHg; Pain: −238 mmHg) during breastfeeding
and milk volume is reduced (Control: 78 mL; Pain: 55 mL) either due to altered tongue
dynamics [117], the strong vacuum itself or reduction of the efficacy of milk removal due
to diminished oxytocin release at ME reflex as a result of the pain [118].
Pump settings influence effectiveness and efficiency of milk removal. For example, it
is only possible to remove substantial volumes of milk from the breast during ME. Thus,
the effective simulation of ME has been a focus of both manual and electric pumping
where patterns have been designed to mimic the breastfeeding infant’s rapid sucking at the
beginning of the feed [119]. We have tested multiple patterns and found that faster patterns
(>100 cycles/min) elicited ME more quickly than slower patterns [20]. Interestingly there
did not seem to be an effect of stronger vacuum in the time to trigger an ME. However, this
was not assessed systematically within a mother, thus it would be prudent for each mother
to set the pump at her maximum comfortable vacuum.
The strength of both infant intra-oral vacuum [95,114] and pump expression vacuum
are implicit in efficacious milk removal [29]. Stronger vacuums during pumping increase
milk flow rate, volume pumped and the cream content at the end of the expression session
as well indicating better breast emptying. Thus it is important for women that need to pump
their milk to test their maximum comfortable vacuum over time as often women are more
sensitive in the immediate days post-partum [120]. Efficacy of milk removal has been shown
to be significantly higher with breast pumps compared to hand expression [115] most likely
due to the absence of vacuum during hand expression and the reliance on internal positive
pressure within the milk ducts only [16]. In this connection, weak vacuums applied
by the infant during breastfeeding may also negatively impact milk removal, requiring
additional expression to achieve adequate breast emptying to maintain or establish milk
production [67,116]. Furthermore, double pumping is more efficacious when compared to
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sequential single pumping, with milk removed during more milk ejections during double
pumping [21].
For the mother using a breast pump, the breast shield is the interface between the
pump and the breast. As such, shield shape, size and characteristics can influence effec-
tiveness of milk removal [19,121]. Based on the fact that warmth is applied to the nipple
by the breastfeeding infant, we investigated whether the application of warmth to the
breast shield would promote more efficient milk removal [95]. We found that the time
to remove 80% of the milk pumped was decreased (4.8 versus 6.8 min) indicating many
women could pump for shorter periods of 5–8 min under these conditions. Ultrasound
imaging supported the results by showing a significant reduction in nipple duct diameter
with cold versus warm ultrasound gel.
In more recent pumping and breastfeeding studies, we measured nipple haemody-
namics using infrared imaging as a proxy for blood flow [33,122]. Nipple temperature
increased during both breastfeeding and pumping. For each 1 ◦C increase in nipple temper-
ature, an additional 10 mL of milk was removed during pumping. It is not clear whether
this increase in temperature is due to the vasodilatory action of oxytocin, local vasodilators,
relaxation of the muscle fibres in the nipple or heating caused by nipple movement in the
breast shield during pumping [98,123,124]. Further, infrared imaging may have potential to
identify atypical nipple responses to feeding/pumping, nipple oedema, and inflammation
that may hinder effective milk removal from the breast [33].
Collectively these results suggest rapid stimulation patterns, stronger vacuums,
warmth, and comfort improve efficacy of milk removal by both the infant and the breast
pump.
Effectiveness of milk removal from the breast is enhanced by:
• Application of vacuum
• Strength of vacuum
• Warmth
• Comfort
• Shield size and design (expression)
• Double pumping (expression)
Table 2. Risk factors for low milk production.
Breast Anatomy/Genetics Breast Physiology
Milk Removal (Autocrine Control)
Infant Pump
No breast growth in





Breast hypoplasia Pregnancy complications Oral anomalies-ankyloglossia Slow stimulation of ME
Breast surgery Maternal endocrine disorders Prematurity Incorrect pump settings(vacuum, vacuum pattern)
Nipple piercing Mastitis Infants exerting strongvacuums and causing pain
Cold conditions-reduce
efficacy of milk removal
Zinc transporter mutations Blocked ducts (temporary) Low tone, Down’s syndrome Pump shield not fittedcorrectly to maternal anatomy
Medications Cleft lip and/or palate
10. Sucking Swallowing and Breathing
Infant sucking is the primary means of receiving nutrition, soothes the infant and
provides the first oromotor exploration experiences [125].
Sucking requires a complex combination of rhythmic movements of the jaw, hyoid
bone, lips, tongue, soft palate, to coordinate with swallowing and breathing. Key anatom-
ical differences exist between the infant and adult oral cavity to facilitate breastfeeding.
The infant’s feeding method impacts growth and development of the jaw and facial struc-
tures, with breastfed infants developing less non-nutritive sucking habits and functional
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disorders such as mouth breathing or atypical swallowing when compared to bottle fed
infants [126–128].
11. Dynamics of Breastfeeding
For many years it was believed that the primary driver of milk removal from the
breast was positive pressure with the infant exerting a peristaltic tongue movement to
squeeze milk from the ducts, with additional pressure applied by the mandible. When a
sufficient bolus volume collected in the oral cavity the medial tongue then moved the milk
bolus to the oral pharynx using a backward-moving wave like motion. The premise for this
theory was based on the existence of lactiferous sinuses that stored substantial volumes
of milk. More recent evidence has shown that lactiferous sinuses are absent and that the
main milk ducts do not in fact store large volumes of milk. Rather, the ME reflex is critical
to transporting milk from the alveoli to the ducts making it available for effective milk
removal [123,124,129].
Seminal studies conducted in our lab that have simultaneously measured intra-oral
vacuum and provided real time ultrasound imaging of the infant tongue during breast-
feeding have shown that the application of vacuum is critical to milk removal from the
breast. The studies have shown that the breastfeeding infant places the mouth over the
nipple and areola to create a seal and enable attachment to the breast. The infant applies
a baseline vacuum (−64 ± 45 mmHg) with the tongue resting in apposition with the
nipple and soft and hard palate. The application of baseline vacuum elongates the nipple,
positioning it close to the nipple hard-soft palate junction (NHSPJ). When the tongue is
lowered the posterior tongue and palate move in unison and vacuum strength increases
(145 ± 58 mmHg) with the nipple moving towards the NHSPJ (Figure 6). The nipple
expands, rendering the nipple ducts visible on ultrasound, and milk flows into the oral
cavity that is bounded by the nipple, palate, and tongue. As the tongue elevates, milk
‘slides’ under the soft palate and is cleared from the oral cavity before the tongue returns
to the palate. [130,131] (Figure 7). We did not observe wave-like or peristaltic movements
of the tongue or squeezing of milk out of the nipple and this has since been confirmed by
others [131,132]. The significance of vacuum as the primary mechanism of milk removal
has also been demonstrated in studies using an electric breast pump. Mothers who pump
at their strongest comfortable vacuum express more milk, more quickly than with weaker
vacuum levels [29]. Furthermore, when infants were fed expressed breast milk from a
vacuum release teat, they used a tongue motion similar to breastfeeding and consumed
comparable volumes of milk [133]. Of note however the peak and baseline vacuums were
weaker than that of breastfeeding most likely due to differences in the structure of the
nipple and teat.
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Figure 7. Ultrasound images of the infant oral cavity during breastfeeding (a) Tongue up position
during breastfeeding. (b) Tongue down is drawn down to create a vacuum and milk flows into the
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Breastfeeding consists of both nutritive (NS) and non-nutritive sucking (NNS). Non-
nutritive sucking typically occurs at the beginning of a breastfeed to stimulate a ME and
near the end of the breastfeed which may serve to satisfy an infant’s urge to suck and
facilitate state regulation and self-comfort [125,134]. These two modes of sucking, NS and
NNS, differ in both vacuum characteristics and tongue motion. Interestingly we have
shown that mean peak vacuums during NS are stronger (−100 vs. −80 mmHg) than
NNS suggesting the infant exerts stronger vacuum to actively remove milk effectively and
efficiently [135].
Over the duration of a breastfeed we have found that peak vacuums do not change but
baseline vacuums become stronger. In addition, sucking frequency for NNS
(104 ± 21 sucks/min) is faster than for NS (89 ± 19 sucks/min) [135]. In contrast, sucking
rates on artificial teats are markedly faster for NS (120 sucks/min) but slower for NS
(60 sucks/min) [134]. The difference is important since it is often assumed that breastfeed-
ing infants should exhibit a slow rhythmic suck when in reality they can vary both their
sucking rate as well as peak and baseline vacuums from one suck burst to the next [136].
Furthermore, NNS suck burst duration is roughly half that of NS (median 4.5 s vs. 7.0 s)
and may be readily apparent on observation of a breastfeed [135].
Suck Swallow Breath Co-Ordination
Efficient and effective feeding is reliant on perfectly timed coordination of sucking,
swallowing and breathing (SSwB) [137]. It has long been purported that a SSwB ratio
of 1:1:1 to 2:1:1 is optimal [138]; however, simultaneous measurement of SSwB during
breastfeeding has shown that this is not the case with SSwB ratios within a breastfeed
displaying enormous variability ranging from 1:1:1 to 12:1:4 during NS [139] (Figure 8).
Thus suck-swallow ratios, a common clinical observation, can change within a breastfeed
in contrast to bottle feeding ratios that are typically more consistent [140]. Similar varia-
tion of suck:breathe and breathe:swallow ratios have been observed and maybe due to
individual patterns of ME suggesting the infants adapts to changing flow rates during
breastfeeding [135].
Maturation of SSwB ratios have been shown to change with infant age and devel-
opment previously [140]. It is likely, however, that milk flow rates and volume increase
rapidly after secretory activation driving the change in sucking and SSwB patterns. How-
ever, once lactation is established, contrary to common belief, we have not found SSwB
ratios to differ from after milk production has been established. The only change we did
detect was longer nutritive suck bursts which were comprised of a greater number of sucks,
swallows and breaths [135].
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but baseline vacuums become stronger. In addition, sucking frequency for NNS (104 ± 21 
sucks/min) is faster than for NS (89 ± 19 sucks/min) [135]. In contrast, sucking rates on 
artificial teats are markedly faster for NS (120 sucks/min) but slower for NS (60 sucks/min) 
[134]. The difference is important since it is often assumed that breastfeeding infants 
should exhibit a slow rhythmic suck when in reality they can vary both their sucking rate 
as well as peak and baseline vacuums from one suck burst to the next [136]. Furthermore, 
NNS suck burst duration is roughly half that of NS (median 4.5 s vs. 7.0 s) and may be 
readily apparent on observation of a breastfeed [135]. 
Suck Swallow Breath Co-Ordination 
Efficient and effective feeding is reliant on perfectly timed coordination of sucking, 
swallowing and breathing (SSwB) [137]. It has long been purported that a SSwB ratio of 
1:1:1 to 2:1:1 is optimal [138]; however, simultaneous measurement of SSwB during breast-
feeding has shown that this is not the case with SSwB ratios within a breastfeed displaying 
enormous variability ranging from 1:1:1 to 12:1:4 during NS [139] (Figure 8). Thus suck-
swallow ratios, a common clinical observation, can change within a breastfeed in contrast 
to bottle feeding ratios that are typically more consistent [140]. Similar variation of 
suck:breathe and breathe:swallow ratios have been observed and maybe due to individual 
patterns of ME suggesting the infants adapts to changing flow rates during breastfeeding 
[135]. 
 
Figure 8. Respiratory traces of a breastfeeding infant using respiratory inductive plethysmography. 
Signals are recorded from the ribcage (yellow) and abdomen (red) and the sum of the two is calcu-
lated (blue). Absence of signal reflects a swallow, downward slope an exhale and upward stope an 
inhale. Geddes et al., unpublished. 
Maturation of SSwB ratios have been shown to change with infant age and develop-
ment previously [140]. It is likely, however, that milk flow rates and volume increase rap-
idly after secretory activation driving the change in sucking and SSwB patterns. However, 
once lactation is established, contrary to common belief, we have not found SSwB ratios 
to differ from after milk production has been established. The only change we did detect 
was longer nutritive suck bursts which were comprised of a greater number of sucks, 
swallows and breaths [135]. 
These comprehensive results also draw attention to clinical signs of swallowing 
which consist of observations of long ‘draws’ during sucking (jaw excursion) accompa-
nied by audible swallows [141]. These clinical signs are unreliable and have not been val-
idated by measurements such as test weights to determine the volume of milk removed 
during a breastfeed [142,143]. 
Figure 8. Respiratory traces of a breastfeeding infant using respiratory inductive plethysmography.
Signals are recorded from the ribcage (yellow) and abdomen (red) and the sum of the two is calculated
(blue). Absence of signal reflects a swallow, downward slope an exh le and upward stope an inhale.
Gedd s et al., unpublished.
These comprehensive results also draw attention to clinical signs of swallowing which
consist of observations of long ‘draws’ during sucking (jaw excursion) accompanied by
audible swallows [141]. These clinical signs are unreliable and have not been validated by
measurements such as test weights to determine the volume of milk removed during a
breastfeed [142,143].
Milk removal by breastfeeding infants
• Tongue motion is one of a ‘piston-like’ motion that expands and compresses the nipple
evenly
• The infant generates a ‘ba eline’ vacuum that raws the nipple and breast int the mouth
creating a seal pri r to sucking
• Drawing the tongue downwards generates stronger vacuum to draw the milk from the
breast
• Moving the tongue upwards reduces the strength of vacuum, compresses the nipple, and
stops milk flow
Coordination of sucking, swallowing, and breathing by breastfeeding infants
• Ratios of sucking, swallowing, and breathing are not consistent nor rhythmic in most
breastfeeding infants
• Suck-swallow-breath ratios likely change in response to changing milk flow rates during
milk ejection
• Suck-swallow-breath ratios differ between nutritive and non-nutritive sucking
• Observation of breastfeeding does not reflect milk removal volumes or patterns
12. Nipple Pain
While intra-oral vacuum is important to milk removal, excessive intra-oral vacuum
has been associated with nipple pain. More than 60 years ago Gunther reported a sucking
intra-oral vacuum up to −200 mmHg in a 2 day-old infant that was associated with nipple
pain and damage [144]. Recently, McClellan et al. [145] reported that infants of mothers
with persistent nipple pain exerted stronger mean baseline (pain: −91 mmHg; no pain
−51 mmHg) and peak intra-oral vacuums (pain: −214 mmHg; no pain: −153 mmHg).
In addition, ultrasound analysis showed reduced tongue movement particularly at the
base of the nipple, resulting in less nipple expansion [117]. Interestingly, positioning of the
nipple with respect to the NHSPJ did not differ in women experiencing pain suggesting
increased breast tissue in the infant’s mouth may not be necessarily beneficial. Indeed, we
have reported a case study of a woman whose infant exerted very strong mean vacuums
(Baseline vacuum: −151 mmHg; Peak vacuum: −233 mmHg) that were not ameliorated
by a nipple shield (Baseline vacuum: −41 mmHg; Peak vacuum: −338 mmHg). Further,
lower milk transfer volumes were observed in infants of mothers with nipple pain (Pain:
42 ± 31 mL; Control:71 ± 31 mL) [146] although it is possible to establish a full milk supply
with assistance [147].
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13. Nipple Shields
Major advances have been made in the understanding breastfeeding and lactation,
sucking dynamics and milk transfer however women experiencing nipple pain remain
understudied despite it being a major cause of early cessation of breastfeeding [148].
Various causes of nipple pain have been identified yet treatment options are limited.
Nipple shields can improve comfort allowing continued breastfeeding [149] however, the
impact of nipple shield use on milk transfer and production is controversial amongst
clinicians [150].
Negative consequences of nipple shield use are based on limited evidence of reduced
milk transfer in term breastfeeding dyads [151] and with shields that are no longer avail-
able [151,152]. In contrast, a pilot study (n = 5) found use of an ultra-thin silicone nipple
shield found no difference in infant milk intake with and without the nipple shield [153].
We have confirmed this in women with persistent nipple pain, showing no reduction in
milk transfer (no shield: 46 mL; shield: 40 mL) nor effectiveness of breast emptying (PAMR;
no shield: 59%; shield 53%) suggesting these infants adapted to the shield and oxytocin
release was not impeded, such that adequate volumes were removed from the breast to
maintain milk production [154]. Importantly in cases of low milk supply, for which we
found incidences of about 35%, these were not associated with levels of pain [147] there-
fore other causes of low milk production such as nipple shield sizing (small shields may
compress nipple ducts), delayed secretory activation, no breast changes during pregnancy,
pregnancy complications, repeated mastitis, infant hospitalization and maternal depression
should considered.
The use of nipple shields did not impact infant sucking dynamics either with infants
displaying similar proportions of the feed in NS and NNS with and without a nipple shield
(NS: shield: 51%; no shield: 58%; NNS: shield: 11%; no shield: 15%). These similarities may
be due to introduction of the nipple shield in the first postnatal week when early imprinting
occurs via communication of somatosensory information from Merkel cells [155] in the
oral cavity to the cerebral cortex [156,157].
Both nipple pain and the subsequent us of a nipple shield use are often assumed
causes of low milk production. The intensity of nipple pain experienced by women during
breastfeeding varies throughout the day and over time [145]. We found an average reduc-
tion in pain of 25% (by McGill pain questionnaire) with use of a nipple shield [158], without
changes in the visual analogue scale scores suggesting the McGill pain questionnaire may
be more sensitive to the nuances and complexities of nipple pain [145]. Indeed persistent
nipple pain is multifactorial and includes predisposing, cognitive and emotional factors
and external influences factors as defined in the Breastfeeding Pain Reasoning Model
complicating its assessment [154]. Importantly and in contrast to assumptions, Chertok
et al. observed that 90% of women who initiated nipple shield use in the first postnatal
week reported a positive experience, and two thirds of women stated that nipple shield
use prevented them from stopping breastfeeding early [159]. Indeed, this data is consistent
with maternal reports of the nipple shield being instrumental in continuing breastfeeding
when experiencing nipple pain/trauma in the early postnatal period.
14. Ankyloglossia
We have found that tongue movement differs in infants with anterior ankyloglossia
(tongue tie) in that they either appear to compress the tip or the base of the nipple during
a suck cycle. This resolved to a more ‘normal’ motion post frenotomy with maternal
pain decreasing during breastfeeding and sucking efficiency increasing (mL/min) [104].
As frenotomy rates have increased so has controversy around definitions of tongue tie,
whether it impacts breastfeeding and who should be treated. Landmark research examining
the anatomy and histology of the lingual frenulum conducted by Mills et al., has been
the impetus for rethinking how to approach tongue-tie and the decision to perform a
frenotomy. Major findings of these dissections have shown that the frenulum is not a
‘band’ or ‘string’ but rather is a dynamic structure comprised of a midline fold of fascia
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that inserts into the internal mandibular arc, creating a diaphragm-like structure spanning
the base of the mouth. Further, genioglossus is suspended from the floor of mouth fascia,
and can be drawn up into the frenulum fold. In addition, the lingual nerve is located
superficially, immediately below the fascia, on the ventral surface of the tongue, making
both genioglossus and the lingual nerve vulnerable to injury during frenotomy [110,111].
Finally, the frenulum contains Type III collagen fibres which are much more distensible
and mobile than the stronger less distensible Type I fibres previously identified [109,160].
Combined, these findings call for tongue tie grading to embrace normal variability and
sheds light on concerns of adverse effects of frenotomy providing the basis for more
prospective studies [107].
15. Preterm Infants
It is now well accepted HM is critical to the health and development of the preterm
infant (born <37 completed weeks gestation). However preterm infants typically are not
born with the sucking skills required to adequately remove milk from the breast. Infants
<34 weeks corrected gestational age may receive all their milk feeds via an intragastric tube
and gradually transition to oral feeds as their sucking skills mature. In neonatal nursery
settings where mothers cannot stay with their infants, bottle feeds may be offered when
the mother is not available to breastfeed.
In the clinical setting preterm milk transfer is usually assessed and estimated through
observation of factors such as sustained latch, audible swallows, and number of suck bursts
per feed. However, when compared to test weighing, we have shown that the subjective
clinical estimates of milk transfer are inaccurate across a range of milk transfer volumes [48]
(Table 3). Of critical importance is that we found that preterm milk transfer is typically
much lower than the prescribed feed volume, and the absence of any milk transfer is not
uncommon [48,116].
Table 3. Percentages of correct estimates of milk transfer as assessed by test weighing [48]. PMA:
post menstrual age.
Infants ≥ 34/40 PMA
n = 902
Infants < 34/40 PMA
n = 284
Minimal or no milk transfer, give full
supplement 98% 99%
Partial feed transferred, give 50%
supplement 29% 16%
Full feed transferred, no supplement needed 47% 91%
Milk transfer is dependent on several maternal and infant factors that cannot be
determined through visual observation. Maternal milk supply and the degree of fullness
of the breast determine the availability of milk during a breastfeed [161] and the infant’s
suck bursts must coordinate with a mother’s ME for the infant to transfer milk [130].
Our seminal research in breastfeeding dynamics has provided the tools to measure
and better understand the sucking characteristics of preterm infants. Geddes’ cross-
sectional study of 40 preterm infants born <34 weeks gestation and corrected gestational
age 32.7–39.9 weeks showed that while preterm breastfeeding infants use a similar suck-
ing action to that of term infants, there are several differences in sucking characteristics.
Most notably, when compared to the mean intraoral vacuum of term breastfeeding in-
fants (−114 ± 50 mmHg [130]) we found the intraoral vacuum of preterm infants was less
than half (−41 ± 28 mmHg, [116]). Similarly, the proportion of the feed time that the
preterm infant spent sucking (38% ± 18%, [162]) was much lower than that of term infants
(82%, [135]). Both the weaker intraoral vacuum and reduced sucking time result in a lower
sucking efficiency [116] and likely contribute to low milk transfer volumes in preterm
infants.
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Nipple shields are routinely used with preterm infants to aid sustained attachment
and facilitate milk transfer [163]. Our sonographic measurements of maternal nipple
diameters for dyads with and without nipple shield use show that nipple diameters are
larger with nipple shield use [116], suggesting the infant can expend less energy attaching
to the breast (i.e., extending the nipple and holding it close to the NHSPJ). This may in part
explain the higher milk transfer volume noted when preterm dyads use a nipple shield.
Additionally, the lower vacuums applied by the preterm infant suggests that when using a
shield, a reasonably full breast would increase the likelihood of greater milk transfer.
We have also shown that when preterm infants are fed with a vacuum release teat,
they are able to remove sufficient volumes of milk using a similar tongue motion as
breastfeeding [164]. In addition, they were discharged earlier [165] and had higher rates
of exclusive breast milk feeding at discharge from hospital and breastfeeding at 3 months
corrected gestational age [166].
Preterm infants have been shown to have a shorter breastfeeding duration than that
of their term counterparts [167]. Early weaning is observed despite a strong maternal
desire to breastfeed with intended durations similar to that of mothers of term infants [47].
Our studies indicate that the greatest barrier to continued breastfeeding beyond discharge
from the neonatal unit is insufficient milk supply, with few other breastfeeding difficulties
cited [47,168]. Mothers that were unable to produce enough milk to meet their infant’s
needs at the time of discharge from hospital were at high risk of early weaning [168]. While
there are concerns about reduced milk transfer with nipple shield use, we found that nipple
shield use at 2 weeks corrected gestational age did not impact breastfeeding to 3 months
corrected gestational age [168]. Our group’s involvement in studies of secretory activation,
milk synthesis and expression intervals in mothers of preterm infants [42,102], as well as
current investigation of the effect of pregnancy complications on secretory activation and
subsequent milk production will contribute to the early management of lactation after
preterm birth.
Factors influencing breastfeeding and milk removal are summarised in Table 4.
Table 4. Factors influencing breastfeeding sucking characteristics and milk removal.
Sucking Milk Removal
Nipple pain Strong intra-oral vacuums (baseline and peak)Compressive tongue motion
May or may not be impacted
Most women can attain a full milk production with
support
Nipple shield Sucking characteristics do not differ significantly
Duration of feeds were longer reducing efficiency
however this is not clinically significant
Women using shields for persistent pain in the first
week of lactation experienced no impact on milk
transfer and effectiveness of breast emptying
Most women can attain a full milk production with
support
Ankyloglossia Anterior tongue tie associated with tongue motioncompressing either the nipple base or tip
Frenotomy for anterior tongue tie ‘normalised’
tongue movement and reduced pain improved
milk production
Frenotomy for posterior tongue tie reduced pain
but did not improve milk production
Prematurity
Weak intra-oral vacuums (both baseline and peak)
Tongue action during breastfeeding similar to term infants
Tongue action with nipple shields similar to breastfeeding
Low milk volumes removed from the breast with
or without a nipple shield
16. Influences of Maternal Body Composition on Milk Composition
Human milk promotes optimum growth, development, and health of the infant; how-
ever the mechanisms that govern both the variation of composition and the pathways by
which it delivers benefits to the infant are not well understood [169]. Increasingly maternal
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and environmental factors are being associated with milk composition. A recent systematic
review indicated maternal adiposity was related to HM lactose and fat concentrations.
However our study failed to confirm these relationships HM [170,171]. We have conducted
several studies, to determine relationships between maternal body composition (BC; lean
and fat mass) and HM composition. We have found that higher maternal BC (%fat mass
(FM), body mass index (BMI)) is associated with increased concentration of whole HM
leptin [171] but not skim HM leptin, which is lower in leptin content [172]. This is consis-
tent with the only other study measuring whole HM leptin using pre-pregnancy BMI as a
measure of adiposity confirming maternal BC may influence HM leptin [173,174]. Variation
of reported relationships between maternal adiposity and leptin depend on methods of
measurement and whether skim or whole milk was analysed as well as number of study
participants. For example, skim HM leptin concentrations in obese mothers (n = 50) were
double of that of normal-weight mothers (n = 50) [175] whereas no differences for whole
HM leptin was found in our smaller longitudinal cohort [176]. Therefore, future analysis
for leptin should be conducted in whole HM.
We have also found that increased maternal BMI is associated with increased HM
cortisol concentration [177]. Indeed individuals with higher BMI have increased circu-
lating cortisol concentrations [178] that could translate to higher concentrations in HM.
Concentrations of these hormones in our study were highly variable within and between
women and remained constant throughout the first 12 months of lactation, suggesting a
more complex relationship between HM glucocorticoids and maternal adiposity.
Like whole HM leptin, higher concentrations of HM protein are associated with in-
creased maternal adiposity and are not identical in all tested cohorts [171,179]. We observed
positive associations between total protein and maternal %FM, but not BMI [171]. In a
longitudinal cohort, we found positive associations between whey protein concentrations
and maternal weight, BMI, fat free mass (FFM), FFM index (FFMI), and FM index (FMI),
with %FM showing no associations [179]. As with leptin, there are studies reporting
both presence and absence of such associations [170]. To add to the complexity further,
we have shown that HM total protein concentration does not change day-to-day [180],
week-to-week [181] or during a short maternal dietary intervention [182].
Increasingly it appears that the mother modulates several components in the milk. We
have not identified associations of maternal adiposity with lactose or total carbohydrates,
nor have we found strong associations with total (estimated) human milk oligosaccharides
(HMO) [183]. However, more recently HMOs have been shown to change with a maternal
dietary intervention [184], mode of delivery and parity [185]. Studies of HMOs and
maternal BMI report conflicting associations [186,187]. Indeed, larger longitudinal studies
including measurement of maternal BC are required to clarify associations with HM
components.
17. Gastric Emptying and Infant Body Composition
Gastric emptying (GE) is a key regulator of appetite [188]. However, there is much
to be learned about the programming potential of HM components, how their patterns
change throughout the lactation period and their impact on the GE rate of the breastfed
infant. Few components, have been investigated in connection with the regulation of infant
milk intake and feeding patterns, including pre-feed gastric residual (GR) volumes and GE
rates of breasted infants.
The absence of suitable validated techniques for the determination of GE has restricted
the evaluation and understanding of GE in the breastfed infant as a mechanism of appetite
control. We have validated an ultrasound technique to assess GE in a preterm popula-
tion [189]. We have also shown that HM components are associated with GE and therefore,
potentially impact infant appetite regulation and BC, evidenced by relationships between
feeding frequency [190,191]; and associations between feeding frequency, milk intake and
infant BC [192].
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Measurements of infant BC have been largely limited to anthropometric measure-
ments such as birthweight, weight, length, head circumference and BMI due to limited
access to comprehensive BC measurement techniques. Recently emphasis has been drawn
to the quality, not just the quantity of growth in the context of childhood obesity. For
example preterm infant BC in early life appears to play an important role in programming
long-term health outcomes including obesity and other non-communicable diseases [193].
As such adult BC measurement techniques are being adapted and to the paediatric popula-
tion, and include bioelectrical impedance spectroscopy (BIS), dual X-ray absorptiometry
(DXA), isotope dilution, magnetic resonance imaging (MRI), ultrasound, whole-body
air-displacement plethysmography (ADP), computed tomography (CT) and others [194].
18. Preterm Infants
Using our validated ultrasound technique in preterm infants [195] we found that GE
of pasteurised donor human milk (PDHM) was slower than mother’s own milk (MOM)
both during feed delivery and the postprandial period [196]. Immediately after feeding,
the volume of PDHM retained in the stomach was 23% higher than MOM, reducing by
15%/30-min until the next feed (3 h). However, the rate of emptying of PDHM is closer to
that of MOM than infant formula, with calculations indicating that postprandial retained
proportions of formula are 23% to 29% higher than that of MOM [197,198]. Final gastric
residual volumes (FGR) were not different between milk types indicating that the same
end point was met for both PDHM and MOM indicating the slower emptying of PDHM
is not detrimental. Further gastric residuals were 12% to 22% of the feed volume, which
is below the 30% to 50% considered a marker of feeding intolerance [199] and supports
clinical observations and evidence that PDHM is unlikely to be implicated in large FGRs
associated with feeding intolerance [200].
Interestingly compositional differences between PDHM and MOM did not explain the
disparity in GE observed in our study. Whilst higher MOM casein and lactose concentra-
tions are associated with faster emptying [201] feeds of PDHM emptied more slowly than
MOM despite having higher concentrations of casein and lactose. It is possible that the
effect of pasteurization or frozen storage alters components of donor HM and so counters
the effects of casein and lactose on emptying. Holder pasteurization also causes complete
inactivation of the bile salt stimulated lipase (BSSL) and lipoproteinlipase [202]. Bile salt
stimulated lipase enables almost complete hydrolysis of HM triacylglycerol through its
synergistic action with pancreatic lipase-related protein 2 [203]. As the presence of lipids in
the duodenum and ileum slows GE through triggering of the ileal brake, it is possible that
restricted lipolysis of pasteurized milk is a mechanism for slower emptying of PDHM [204].
Also, heat treatment of bovine milk has been shown to alter the structure of whey proteins
resulting in interactions between denatured whey proteins and casein micelles [205]. It is
therefore conceivable that Holder pasteurization creates similar interactions in HM possibly
negating the faster GE associated with higher human casein concentrations.
We found no evidence to support a difference in GE according to infant sex. We did
detect faster GE during feed delivery in male infants however this was explained by the
lactose concentrations of PDHM fed to male infants that were on average 6.1 g/L and
14.2 g/L higher than that of PDHM and MOM fed to females [196].
There is limited evidence of a relationship between energy concentration and GE in
preterm infants. Our studies show that the energy concentration of HM feeds ranging
from 12.6–30.4 kcal/30 mL did not influence GE, likely because triacylglycerol, the pre-
dominant HM lipid that contributes to HM energy density, differs from other lipid sources
in that it does not trigger the ileal brake to slow GE [197,206,207] (refs). The preterm
infant’s diminished GE response to increasing lipid and energy concentrations may serve
to facilitate the physiological emptying of fat-rich HM that is ingested towards the end
of a breastfeed [65]. Our GE rates are similar to those observed for MOM and formula
feeds of 5–20 kcal/30 mL [208]. In contrast, an older study reported increasing energy
concentrations were associated with slower postprandial emptying for formula feeds of
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5–20 kcal/30 mL from 20 min post feed, with differences between 20 kcal and 24 kcal noted
only at 80 min post feed [209]. The study did not account for the osmolality or specific
nutrient concentrations of the bovine-based formula feeds which differ from HM and are
known to influence gastric emptying [206].
Our ultrasound technique also allows assessment of the effect of the addition of human
milk fortifier (HMF) to HM feeds on GE. When bovine-based HMF was added to achieve
an assumed caloric density of 24 cal/30 mL, slower GE was observed across all 30-min time
points between feeds [196]. The magnitude of the effect was smaller for PDHM than for
MOM, possibly due to differing interactions/digestion of HMF between MOM and PDHM
due to the degradation of several HM bioactive factors by heat pasteurization. This finding
concurs with Ewer & Yu who reported an average gastric half emptying time of fortified
MOM to be 48 min, more than double the 21 min average for unfortified MOM [210].
Supine infant positioning was associated with slower GE with retained feed propor-
tions on average 16% higher than that of infants positioned prone or right lateral across the
postprandial period [196]. The observed inter-individual effects of positioning on GE are
consistent with several published studies [211,212] and further support the use of prone
positioning as a conservative clinical management strategy for feeding intolerance in the
neonatal unit setting.
A gastric residual volume ≤2.5 mL that is predominantly curd appears to be usual for
stable preterm infants [213], with most (62%) 3 hourly feeds resulting in empty stomachs.
This finding raises the possibility that feeding of 3 hourly volumes may be tolerated if fed
every 2.5 h. The gastric residual, as a proportion of the feed volume, was similar between
MOM and PDHM and were 10% and 15% for unfortified and fortified feeds respectively.
These are similar to the 15% and 16% residual feed proportions reported for MOM and
infant formula, respectively [207,214] and below the 30%−50% considered to be a sign of
feeding intolerance [199].
Sonographic examination of gastric contents after HM feeds showed that the presence
of curding, and its echogenicity, or density, were similar for MOM and PDHM. Immediate
post feed ratings of high curd density and high curd volume were associated with higher
HM casein concentration, and HMF also significantly contributed to high curd volume [189].
As neither of the two HMF products used in the study contained casein, it is likely the higher
curd volume and density associated with HMF resulted from a more acidic environment
caused by HMF that facilitates HM protein precipitation [215]. The presence of small
curd volume in the stomach suggests there is continued delivery of nutrients to the ileum
beyond emptying of the liquid portion of a human milk feed.
Our gastric emptying studies confirm that HM is well tolerated by the preterm infant;
despite changing composition over time and between women, no clinically significant im-
pact on gastric emptying is observed. Current heat treatment of donor HM and commercial
HMF products slow GE somewhat but not to the degree that causes feeding intolerance
in medically stable preterm infants. Further, with complete emptying of 3-hourly feed
volumes typical for many infants, it may be possible to explore more frequent feeding of
similar volumes when additional caloric intake is indicated.
Infants born preterm are susceptible to postnatal growth restriction and will benefit
from aggressive nutritional management in order to achieve optimal growth and BC
parameters. Body composition measurements in preterm infants are difficult to obtain due
to compromised health and physical limitations such as their fragile skin that prevents the
use of callipers, the need to avoid frequent blood collection (e.g., tracer dilution techniques)
and increased susceptibility to radiation. They are also relatively overhydrated, with
higher body water content compared to children and adults, leading to overestimation
of FFM when using bioelectrical impedance analysis [216]. This leaves few methods
that are suitable for the hospitalised preterm infant with limitations due to the risks of
overhandling, infection, and thermal instability. Previous studies have reported lower FFM,
and higher FM compared with term infants at hospital discharge, thus increasing their risk
of developmental issues, metabolic syndrome, and obesity later in life [217–219].
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We have found, with air displacement plethysmography that there were relationships
between milk composition and changes in BC preterm infants fed fortified HM. Increased
fat and total energy intakes were associated with increasing FM whilst increasing protein
intake when considered with carbohydrate intake was associated with increasing FFM [220].
We have also established that ultrasound is sensitive enough to detect HM macronutrient-
related changes in accrued adipose and muscle tissue measured at multiple sites: abdomen,
scapula, mid-thigh and mid-arm in preterm infants [221]. Enteral volumes (predominately
HM) were positively associated with adipose to muscle ratio whilst timing of fortification,
carbohydrate intake and the protein energy ratio of intakes moderated ratio of the adipose
to muscle tissue accretion in preterm infants. This study demonstrated that ultrasound may
offer a clinically useful tool to obtain non-invasive obtain serial infant BC measurements.
Gastric emptying of preterm infants
• Gastric emptying rate of pasteurised donor human milk (PDHM) is more similar to mothers’
own milk (MOM) than infant formula
• Final gastric residual volumes for PDHM and MOM are similar
• Final gastric residual volumes for PDHM and MOM at 12–22%
• Human milk casein and lactose impact gastric emptying
• Gastric emptying does not differ by infant sex
• Fortification of MOM and PDHM slows gastric emptying
• Supine position of infant slows gastric emptying
• MOM and PDHM produce similar curding patterns
Body composition of preterm infants
• Increased fat and total energy intakes are related to increasing fat mass
• Increasing protein intake when considered with carbohydrate intake is related to increasing
fat-free mass
• Enteral volumes are positively associated with adipose to muscle ratio
• Timing of fortification, carbohydrate intake and protein energy ratio of intakes moderate
ratio of the adipose to muscle tissue accretion
19. Term Infants
There is evidence of differences in GE between infants fed infant formula compared
to those fed HM, yet breastfed infants have not been studied in depth with respect to
milk composition. We have investigated the effects of multiple factors, including appetite
hormones, macronutrients, BC and maternal factors, on GE.
We found higher feed volumes were associated with faster GE rate, higher post-feed
stomach volumes, and longer GE times. Greater feed volumes were also associated with
smaller residual volumes prior to the feed and larger residual volumes prior to the next
feed. Importantly, during exclusive breastfeeding period we found no effect of infant
age or sex on feed volume, GE or breastfeeding patterns, but larger (not older) infants
with higher adiposity had longer time between feeds, indicating a potential link between
feeding frequency, GE, and BC. It also implies that feeding frequency is dictated by an
individual’s growth rate and development rather than age, providing further support for
breastfeeding on demand for the duration of the breastfeeding relationship.
20. Proteins
We have found that specific protein composition rather than total protein appears to
influence GE either indirectly or directly. For example, the casein:whey ratio modified the
GE rate depending on the volume of milk consumed, such that higher casein:whey ratios
were associated with faster GE of small feed volumes and a slower GE rate of larger feed
volumes [190]. Furthermore, higher casein concentrations and intakes were associated with
shorter GE time, which may result in higher feeding frequency, and in turn, higher 24 h
milk intake and infant adiposity (Figure 9). In this cohort the association between feeding
frequency and infant adiposity strengthened with duration of lactation, consistent with
Ay et al. [222]. In contrast to casein, higher whey protein concentrations and intakes were
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associated with longer GE time [190], which may result in lower milk intake and reduced
adiposity [192] (Figure 9). Thus, both feeding frequency and GE are in part likely regulated
by HM casein and whey concentration. However, it was not the casein concentration
but daily intake of casein that was directly associated with infant BC; negatively with
lean mass and positively with FM with associations strengthening in the later months of
lactation [179]. This suggests that higher daily doses of casein may down-regulate the
accrual of lean body mass in infants, potentially by decreasing time between feeds and
increasing the volume of milk consumed. These results further clarify role of the HM
protein as a potent appetite regulator and draw attention to the importance of the HM
protein composition.
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ponents with infant gastric emptying factors and breastfeeding parameters, these relationships have 
been included and could be integrated into possible pathway. Grey arrows indicate further possible 
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volumes; − negative association; + positive association. Purple arrows indicate the direct associ-
ations between components and infant BC. In the case where direct relationships between infant
body composition and human milk components are supported by the relationships of human milk
components with infant gastric emptying factors and breastfeeding parameters, these relationships
have been included and could be integrated into possible pathway. Grey arrows indicate further
possible pathways, although no direct association of component unit with infant body composition
has been established (or not analysed in case of doses).
21. Immune Factors
HM contains multiple immunological factors that provide protection against var-
ious health challenges [223–225]. Within the whey fraction, lactoferrin, lysozyme and
sIgA are present in high concentrations, potentially indicating multiple roles in infant
programming [226,227]. We have shown that these bioactive components relate positively
to breastfeeding frequency (sIgA) and milk intake (lysozyme, sIgA), and that these re-
lationships extend further to infant BC [228] (Figure 10). Higher lactoferrin intake was
associated with lower infant FFM index whilst higher lysozyme intake related to higher
infant adiposity. Although not associated with maternal BC, the concentrations of these
components continued to increase throughout the first year of lactation, ensuring the same
level of infant protection despite the reduction in milk intake.
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Lactoferrin is being explored as clinical intervention for infant health [229], and for
the first time we have evaluated how natural variations of this HM component relate to
BC of term breastfed infants. The observed negative relationship of lactoferrin intake with
infant lean mass could be explained by modulation of infant gut microbiome [230], as
the gut microbiome has been implicated in infant weight gain and obesity [231], as well
as by increasing the bioavailability of iron to the infant. Iron supplementation in iron
replete infants has been shown both to decrease linear growth and weight [232]. The exact
mechanisms of these outcomes are not clear and interactions between lactoferrin and infant
growth appear complex requiring further study.
Lysozyme is important not only for the immune protection of the infant but for infant
growth and now BC as we have shown a positive relationship with FM and negative with
FFM [228]. Preterm infants have exhibited better growth and improved gastrointestinal
function when administered lysozyme [233]. The effects of HM lysozyme may be mediated
through improvement of infant gut health and optimized digestion, resulting in increased
absorption of nutrients and subsequently, increased fat accretion. Or alternatively, that
lysozyme, not unlike leptin, also enhances innate and adaptive immune responses [234],
therefore lysozyme may also be implicated in the two-way relationship between the obesity
and immune status.
Whilst HM sIgA demonstrated no strong associations with infant BC, daily intake was
positively associated with breastfeeding frequency which in turn is also related to 24 h milk
intake (Figure 10), potentially affecting infant adiposity. Like lysozyme, broad spectrum of
sIgA antibodies are implicated in the development of infant mucosa and anti-inflammatory
and tissue protective activities [235]. These findings warrant further investigation of other
immunological factors of HM in relation to infant growth and BC.
Nutrients 2021, 13, 3071 25 of 46
22. Appetite Hormones
HM hosts a plethora of hormones that are biologically active, including adipokines and
glucocorticoids that may programme appetite [236], and we have found interesting relation-
ships of HM adiponectin with infant GE. Higher concentrations and intakes of adiponectin
were associated with longer times between feeds in term breastfed infants [190], which
may be implicated in the growth-regulating effect of adiponectin in the first 4–7 months
of life, evidenced by high HM adiponectin concentrations being associated with lower
infant weight and FFM [176]. Extended GE times may culminate in fewer feeds per day
and potentially lower 24-h milk intake, restricting both volume and energy to the infant
and slowing growth. This hypothesis is further supported by our longitudinal study of
infant BC that showed that higher HM adiponectin intake being associated with lower
infant lean mass and increased adiposity over the first year of life [176].
Whole HM leptin content did not display any associations with GE or breastfeeding
parameters [190] (Figure 11), indicating that long-term effects of leptin in human infants are
possibly stronger than the potential short-term satiety effects observed in rodent models.
This also highlights the difficulty of extrapolating results in animal models to humans [237].
However, HM leptin intake is related to infant feeding frequency and BC development,
with higher daily intake of both, whole and skim milk leptin associating with greater
deposition of adipose tissue [176]. Skim milk, however, is not representative of what infant
ingests and results for skim milk leptin should be interpreted with caution.
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Figure 11. Possible pathways of lactocrine programming of the infant by the human milk appetite
hormones. BMI—body mass index; CDI—calculated daily intakes; Conc.—concentrations; doses—
amounts of human milk component ingested during a single breastfeed; FFM—fat-free mass; FM—fat
mass; %FM—percentage fat mass; GE—gastric emptying; MI—milk intake; − negative association;
+ positive association. Purple arrows indicate the direct associations between components and
infant BC. In the case where direct relationships between infant body composition and human
milk components are supported by the relationships of human milk components and infant gastric
emptying factors and breastfeeding parameters, these relationships have been included and could be
integrated into possible pathway. Grey arrows indicate further possible pathway, although no direct
association of component unit with infant body composition has been established.
23. Glucocorticoids
HM contains the glucocorticoids, cortisol, and cortisone, which are involved in regula-
tion of inflammation and metabolic homeostasis and may impact infant gut maturation and
the microbiome [238]. Little is known about how these hormones affect infant growth and
development of BC. For the first time we reported that higher concentrations of HM cortisol
Nutrients 2021, 13, 3071 26 of 46
and cortisol to cortisone ratio are related to greater infant adiposity [177]. Elevated circula-
tory cortisol is known to be a potent stimulator of body fat mass gain in adults [239,240]
and recently in 2-year-olds [241].
Additionally, cortisol was positively related to head circumference, an important
indicator of infant brain size and a proxy for intracranial volume, neurological development
and cognitive function [242] all of which are commensurate with breastfeeding [243,244].
The cortisone relationship with head circumference the reverse of that reported for chronic
prenatal maternal stress during pregnancy (smaller head circumference) [245] (Figure 12).
Whilst underlying mechanisms for these associations are unclear, these findings should be
confirmed with daily infant intakes of glucocorticoids in addition to concentrations.
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24. Carbohydrates 
Our research has also provided new insights about relationships of HM carbohy-
drates with infant GE [190] (Figure 13). We have found that both total carbohydrates and 
lactose are associated with GE, feeding frequency and infant 24 h milk intake culminating 
in relationships to adiposity [190] (Figure 13). This highlights the complexity of pathways 
affected by HM components and that infant intake, as evidenced by our finding that 
higher lactose concentrations are associated with slower GE rate of small feed volumes 
and faster GE rate of large feed volumes [190]. These results support the findings of Khan 
Figure 12. Possible pathways of lactocrine programming of the infant by the human milk glucocor-
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24. Carbohydrates
Our as also provided new insights about relationships of HM carbohydrates
with infant GE [190] (Figure 13). We have found that bo total carbohydrates and lactose
re associated with GE, feeding frequency and i fant 24 h milk ntake culminating in
relationships to adiposity [190] (Figure 13). This highli ts t t s
a fecte components and that infant intake, as evid nced by our finding that hig er
lactose concentrations are as ociated with slo er GE rate of sm ll feed vo um s and faster
GE r te of large feed volum s [190]. These results suppor the findings of Khan et al. [65]
who reported a positive association between lactose concentration and feeding frequency.
We have reported that concentrations and, more importantly, daily intakes of HM
carbohydrates are associated with development of infant BC and are differentially related
to infant anthropometry and BC [183]. Furthermore, the directions of the associations with
infant BC were not uniform for the daily intake and concentration of the same measured
carbohydrate. Lactose concentration showed no associations with infant BC, yet lactose
intakes were negatively associated with lean mass and positively with FM. Intake of total
carbohydrates showed similar relationships with lean and fat mass, but relationships with
concentration were reversed with more carbohydrate associating with more lean mass, less
adiposity and higher infant length and weight.
Nutrients 2021, 13, 3071 27 of 46
Nutrients 2021, 13, 3071 28 of 48 
 
 
et al. [65] who reported a positive association between lactose concentration and feeding 
frequency. 
We have reported that concentrations and, more importantly, daily intakes of HM 
carbohydrates are associated with development of infant BC and are differentially related 
to infant anthropometry and BC [183]. Furthermore, the directions of the associations with 
infant BC were not uniform for the daily intake and concentration of the same measured 
carbohydrate. Lactose concentration showed no associations with infant BC, yet lactose 
intakes were negatively associated with lean mass and positively with FM. Intake of total 
carbohydrates showed similar relationships with lean and fat mass, but relationships with 
concentration were reversed with more carbohydrate associating with more lean mass, 
less adiposity and higher infant length and weight. 
Whilst we did not directly measure concentrations of HMO in our cohort, we found 
that like total carbohydrates, total HMO concentration related positively to infant lean 
mass and negatively to adiposity, yet intake of HMO displayed no associations. Of note, 
HMO intake remained the same over 12 months post-partum. Our results support recent 
findings of differential associations between individual HMO and infant BC [246]. Total 
HMO on the other hand had no impact on infant GE which was expected as HMOs target 
the small intestine and have been shown to modulate the gut microbiome therefore, hav-
ing an indirect effect on BC [247]. 
 
Figure 13. Possible pathways of lactocrine programming of the infant by the human milk carbohy-
drates. BMI—body mass index; CDI—calculated daily intakes; Conc.—concentrations; doses—
amounts of human milk component ingested during a single breastfeed; FFM—fat-free mass; FM—
fat mass; GE—gastric emptying; HMO—human milk oligosaccharides; MI—milk intake; − negative 
association; + positive association. Purple arrows indicate the direct associations between compo-
nents and infant BC. In the case where direct relationships between infant body composition and 
human milk components are supported by the relationships of human milk components with infant 
gastric emptying factors and breastfeeding parameters, these relationships have been included and 
could be integrated into possible pathway. Grey arrows indicate further possible pathways, alt-
hough no direct association of component unit with infant body composition has been established 
(or not analysed in case of doses). 
Given contrasting relationships of HM component concentrations and intakes, infant 
intake of components may well reflect better the nutritional physiology of the breastfed 
infant. These findings also indicate the possibility of intervention via modulation of both 
milk intake and the infant gut microbiome, which is implicated in adiposity and develop-
ment of obesity [248]. 
i re 13. Possible pathways of lactocrine progra ming of the infant by the human milk carbo-
hydrates. BMI—body mass index; CDI—calculated daily intakes; Conc. concentrations; doses
amounts of human milk component ingested during a single breastfeed; FFM—fat-free mass; FM—fat
mass; GE—gastric emptying; HMO—human milk oligosaccharides; MI—milk intake; − negative
association; + positive association. Purple arrows indicate the direct associations between compo-
nents and infant BC. In the case where direct relationships between infant body composition and
human ilk components are supported by the relationships of human milk components with infant
gastric mp ying factors and breastfeeding paramete s, these relationships have e n included and
c ld be integrated into p ssible pathway. Grey arrows indicate further possible pathways, lthough
no direct association of component unit with infant body composition has been established (or not
analysed in case of doses).
Whilst we did not directly m asure concentrations f HMO in our c hort, we foun
that like total carbohydrates, total HMO concentrat on elated positively to nfant lean
ass and negativ ly to adiposity, yet intake of HMO displayed no ass ciations. Of n te,
HMO intake remained the same over 12 months post-partum. Our results support recent
findings of differential associations between individual HMO and infant BC [246]. Total
HMO on the other hand had no impact on infant GE which was expected as HMOs target
the small intestine and have been shown to modulate the gut microbiome therefore, having
an indirect effect on BC [247].
Given contrasting relationships of HM component concentrations and intakes, infant
intake of components may well reflect better the nutritional physiology of the breastfed
infant. These findings also indicate the possibility of intervention via modulation of
both milk intake and the infant gut microbiome, which is implicated in adiposity and
development of obesity [248].
25. Lipids
HM lipid fraction accounts for 50% of the energy content and is thus an important
contributor to infant growth. Dose or concentration of HM fat showed no effect on term
infant GE rate or time [190], consistent with lack of associations between fat and feeding
frequency reported previously [60,65]. Higher HM fat intakes have been associated with
lower weight-for-age z-scores [249], but also higher weight gain [250]. Higher 24-h fat and
total energy intakes have also been associated with higher infant weight and FFM at 3, 6
and 12 months [251]. These studies should be interpreted with caution due to sampling of
HM lipid not being straight forward. Total fat increases across a breastfeed and changes
throughout the day due to the relationship between fat content and the fullness of the
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breast [63,252]. As such sampling is problematic with one sample not being representative
of either fat content or infant fat intake as illustrated by George et al. [253]. Further,
analysis differs according to analytical technique, with the creamatocrit method offering an
attractive alternative to more complex biochemical assays [254,255] such that it could be
integrated into the clinical practice, particularly in the area of preterm nutrition, to increase
the energy content of milk [256].
Gastric emptying in term infants
• Increased feed volumes associate with faster rates of gastric emptying but longer gastric
emptying times.
• Infant sex and age did not relate to gastric emptying characteristics
• Larger infants had longer times between feeds
• Casein:whey ratios influence gastric emptying rate according to volume of the feed
• Infant intakes of adiponectin are associated with longer times between feeds
• Infant intake of whole HM leptin is positively associated with feeding frequency in first
5 months of lactation
Body composition of term infants
• Infant casein, lactose and total carbohydrate intake has a positive association with infant fat
mass and a negative one with infant lean mass
• Infant lactoferrin intake has a negative relationship with infant lean mass
• Infant lysozyme and whole HM leptin intake have a positive relationship with infant fat
mass
26. Infant Health
HM is much more than the nutrition that supports optimal infant growth. It is a
compositionally complex and dynamic fluid that supports both the innate and adaptive
infant immune system [257]. Many milk components have dual roles in the nutrition and
protection of the infant. For example, lipids are most often regarded as nutrition but there
is mounting evidence of their association with health. Using new methods [258] we have
recently discovered 98 novel triaclyerglicerides (TAGs) and found that infant intake of
palmitic acid-containing and lauric acid-containing TAGs differed between healthy and
unwell infants indicating responsiveness of the milk [259]. This is consistent with our
previous study that showed reductions in the proportion of capric (C10:0) and lauric acids
and increases in palmitoleic and stearic acid [260] in unwell mothers and infants. Indeed it
also highlights both the importance of measuring component intake [261] and with respect
to total lipid employing extensive sampling [253].
Similarly, we have documented increases in the leukocyte content in response to
maternal and/or infant infection. The smallest response was seen if only infant was ill
and the greatest with maternal mastitis and upon recovery leukocyte content returned to
the health baseline level. This increase in leukocytes was also accompanied by significant
changes in lactoferrin, sIgA IgG, and IgM concentrations [262].
These changes in the milk components as responses to maternal and infant health
hold promise potential therapies; however this work is hampered by the ability to isolate
components and scale up their production [263]. In contrast, modulation of milk via
maternal interventions may improve health in an individualised fashion.
27. Human Milk Microbiome
The development of the gut microbiome in the first years of life has been strongly
associated with immune and metabolic outcomes in large human cohort studies, and in in-
terventional animal models [264]. Importantly, HM shapes the infant microbiome through
direct transfer of bacteria as well as bioactive components such as HMOs, antimicrobial
proteins, and short chain fatty acids (SCFAs) [265]. The human milk microbiome (HMM) is
therefore of great interest as a target for developmental programming of health. However,
while the composition of the HMM has been extensively characterised ([265]), little is
known about the origins of this community or the host-microbiome interactions at the
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breast. Host-microbe and microbe-microbe interactions in the lactating mammary gland
are likely to be highly complex. Inter-kingdom interactions between human cells, bacteria,
fungi, and viruses, as well as interactions involving host-derived and microbe-derived
bioactives likely influence mammary gland and infant health (Figure 14). Indeed, it is not
even known whether the lactating mammary gland hosts a permanent resident microbiome,
or whether bacteria are bought in from exogenous locations (such as the maternal gut or
infant oral cavity) and survive temporarily before being swept out of the breast via a ME
(Figure 14). Stinson et al. have described these two possibilities as the “mucosal interface
model” and the “constant influx model”, respectively [265]. Regardless of whether the
bacteria detected in milk are permanent residents or mere “tourists”, numerous HMM
taxa have been shown to be vertically transferred from mother to infant via milk [266–269].
Factors that shape HMM composition, such as maternal diet, may thereby influence infant
colonisation dynamics, with implications for infant health. The potential for maternal diet
during lactation to influence infant gut microbiome dynamics has been reviewed exten-
sively by Sindi et al. [270]. This evidence, from observational human studies and animal
models, paves the way for future intervention studies to assess the impact of maternal diet
on infant microbial development.
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integrative analysis of these components is required. 
In addition to live bacteria, HM also contains the products of bacterial metabolism, 
such as SCFAs. These immunomodulatory metabolites SCFAs (formate, acetate, propio-
nate, butyrate, and valerate) are the end products of bacterial fermentation of fibre in the 
gut and are transported systemically around the body, including to the lactating mam-
mary gland. They have been shown to elicit a broad range of immunological effects, in-
cluding promotion of regulatory T cell responses and immune tolerance, synthesis of den-
dritic cell precursors, and epithelial barrier integrity in the gut [273–275]. HM therefore 
has a two-fold influence on infant health: by directly seeding the infant microbiome with 
human milk bacteria, and by exposing the infant to bacterial metabolites formed in the 
maternal gut. Emerging evidence suggests that SCFAs may protect infants from develop-
ing atopic disease [273,276]. Our research has shown that milk from atopic mothers con-
tains a significantly reduced concentration of SCFAs compared to that of healthy mothers 
[277]. This finding may in part explain why breastfeeding does not protect against atopy 
if the mother herself is atopic [278,279]. HM SCFAs have also been associated with infant 
BC [280]. They are therefore of interest for both infant growth and infant immune devel-
opment. Given that maternal SCFA levels may be modulated by diet, these bacterially 
derived metabolites represent an exciting opportunity for intervention to optimise infant 
health. 
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and epithelial barrier integrity in the gut [273–275]. HM therefore has a two-fold influence
on infant health: by directly seeding the infant microbiome with human milk bacteria,
and by exposing the infant to bacterial metabolites formed in the maternal gut. Emerging
evidence suggests that SCFAs may protect infants from developing atopic disease [273,276].
Our research has shown that milk from atopic mothers contains a significantly reduced
concentration of SCFAs compared to that of healthy mothers [277]. This finding may in
part explain why breastfeeding does not protect against atopy if the mother herself is
atopic [278,279]. HM SCFAs have also been associated with infant BC [280]. They are
therefore of interest for both infant growth and infant immune development. Given that
maternal SCFA levels may be modulated by diet, these bacterially derived metabolites
represent an exciting opportunity for intervention to optimise infant health.
Our group has established methodologies for studying the HMM from collection to
analysis. We demonstrated that milk expressed using an electric breast pump does not
differ in its bacterial composition to milk expressed by hand [281]. This finding is reassuring
for those designing HMM studies. We also assessed four commercial DNA extraction kits
for their ability to extract DNA from HM [282]. We found that two of the kits could
not reliably extract DNA from HM. Of the two remaining kits, a similar bacterial DNA
profile was extracted, but one kit co-extracted a high level of contaminants. Such inter-kit
variability may help to explain some of the variation seen in HMM composition between
studies. A significant challenge in working with HM is the fat fraction, which interferes
with DNA extraction. This fraction is therefore routinely discarded prior to DNA extraction
in HMM studies. We demonstrated that this fraction contains bacterial DNA, suggesting
that bacteria may be trapped in the lipid layer by milk fat globule membranes [283,284].
However, reassuringly, the fat fraction did not differ in bacterial composition to the cell
pellet, suggesting that discarding the fat fraction prior to extraction would not alter the
composition of bacteria detected downstream. This is particularly important, as we have
shown that inclusion of the fat fraction reduces DNA extraction efficiency by ~40% [283].
By focusing on robust methodologies for reproducible data, we have raised the standards
of the field.
28. Donor Human Milk
In past decades there has been a resurgence in the establishment of donor milk banks
in an effort to provide HM for vulnerable infants [285]. Donor milk has been shown to
have positive effects of infant mortality and morbidity [286] whilst being economically cost
effective [287]. We have been active in the formulation of best practice in milk banking
which varies according to geography and resources [288] as well as investigating pas-
teurization methods. Thermal pasteurization of milk is almost universal in milk banks
however in the process of eliminating bacteria and most viruses [289,290] bioactivity is
often dramatically reduced [291]. Reduction in the loss of bioactivity can be altered by
reduction in pasteurization temperature [292], combinations of time and temperature, as
well as other technologies [291,293]. Our group has pioneered UV-C treatment [294] in an
effort to preserve the bioactivity of protective components in milk. It shows great promise
in eliminating bacteria [295] including cytomegalovirus [296] not at the expense of immune
protein activity [297]. More recently we investigated the heat stable enterotoxin produced
by the potential pathogen S. aureus. S. aureus enterotoxins are linked to gastritis and necro-
tizing enterocolitis. Spike in experiments (S. aureus, and enterotoxin) at various storage
temperatures and times confirmed a rapid decline in both the bacteria and enterotoxin
in raw and UV-C treated milk providing more evidence of promise for this method of
processing donor milk [298,299].
29. Human Milk Cellular Content
HM cell studies offer insight into the biosynthesis pathways involved in milk secretion,
the microenvironment of the lactating mammary gland and the potential physiological role
of HM cells for the developing infant.
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Cells can be isolated through centrifugation of milk and have been found to be
enriched in micro-RNA (miRNA), which are regulatory biomolecules, that potentially
play a role in infant development [300]. Whilst cell content of milk is variable, it has been
found that the greatest number of cells can be isolated when milk samples are collected
30 min post-feed [301]. It should be noted, however, that not all milk-derived membrane
enclosed structures (resembling cells) bear a nucleus, and that some are instead enlarged
milk fat globules [302] (Figure 15). Why cells enter milk is still a mystery, however it has
been found that a subset of cells appear to survive the infant gastrointestinal tract which
may potentially impact the receiving offspring [303]. Indeed, we have shown that the
immune cell compartment of milk changes depending on the health status of the mother
and infant [262] which may lead to a downstream protection for the vulnerable child.
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Together with immune cells, milk also contains maternal epithelial cells which through
analysis may provide insights into the maturation and function of the lactating mammary
gland. An early study found that prior to culture, milk cells predominantly expressed
the luminal cell arker keratin 18 (CK18), and after culture the cells expressed markers
associated with progenitors (CK5, Nestin) and myoepithelial cells (CK14) [304]. This
culture-inducible epithelial lineage plasticity of milk cells is thought to be regulated, in part,
by Sigma (14-3-3σ) [305]. Further st dies by our group have found that under different
culture conditions, milk cells expressed markers associated with tissues derived from all
three embryonic layers [306]. Moreover, milk cells were found to express the pluripotent
stem cell transcriptio factors OCT4, S X2 and NANOG on a pr tein and mRNA level.
These findings paralleled studie in non-preg ant, non-lactating breast tissue published
around the same time [307,308]. Whilst the conc pt of pluripotent mammary stem cells
existing in HM has been ext sively reviewed [309] few studies have provided supporting
evide ce, suggesting th need for more targeted research.
In t is recently been great advances in the t ols available
to ch racterise ma mary cell differen ation c pab lities (i.e., stemnes ), such as in vivo
lineage tracing studies ( hat allow tracking the progeny of a sing e cell t r ugh organ
development) and technologies that allow for unbiased cell subtype identification uch
as single-cell RNA-sequencing/Assay for Transpo ase-Accessible Chromatin (sc -
seq/s -seq) [310]. in ings fro any of these studies suggest that cells in the adult
a ary gland are unipotent under ho eostatic conditions and only acquire stem cell
characteristics in artificial reprogram ing environments [311] (such as ex vivo cell culture).
Increasing numbers of sc-RNA-seq studies have attempted to profile human mammary
cells from different stages of development in an attempt to further unravel the subpopula-
tions of cells that exist in the breast [312]. In line with findings from lineage tracing studies,
a study examining breast tissue taken from adult non-pregnant, non-lactating individuals
did not find a quiescent niche of mammary stem cells [313]. Recently, two studies have
examined cells isolated from HM via scRNA-seq and found that milk contains predomi-
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nantly luminal and immune cells [314,315]. Whilst both studies concur that luminal milk
cells have a similar gene expression profile to luminal progenitor cells from the breast,
pluripotent transcription factors were not found to be co-expressed at a detectable levels in
single cells, nor expressed at higher levels than the cells isolated from the normal resting
breast ([315]). Interestingly however, the milk luminal cells appear to be heterogeneous,
consisting of two major luminal subtypes LC1 and LC2. In particular, one of these milk
luminal cell subpopulations expressed higher levels of immunomodulatory and antigen
presenting genes suggesting potential cross talk between the epithelial compartment with
the microenvironment of the lactating mammary gland. Whilst many questions remain of
the role and function of cells in milk, further investigation of these cells is warranted and
may provide further excellent insights into the biology of milk secretion and the immune
and developmental role milk plays for the breastfed infant.
30. Breastfeeding during COVID
As the COVID-19 pandemic continues to impact society, women have been dispropor-
tionally affected by the consequences of the virus. Mothers have faced an increasing burden
of tasks around the home, parenting, educational, and broader family support roles, and
make-up the most significant portion of the frontline health workforce [316]. Inconsistent
and detrimental policy changes have negatively impacted pregnant and lactating women in
particular. Due to uncertainty about mother-to-infant transmission of acute respiratory syn-
drome coronavirus 2 (SARS-Cov-2), many hospitals and governments rapidly brought in
policies to prevent transmission early in the pandemic. These included restricting women’s
access to support people during labour, isolating mothers with confirmed or suspected
infection from their infants and discharging women early from the hospital. Moreover,
families have received conflicting advice on whether to breastfeed directly or not and once
at home, breastfeeding women experienced reduced access to lactation and mental health
support [317–319].
The overwhelming evidence contradicts fears that the mother may transmit the virus
to her infant via her milk [101,317] with no study to date demonstrating that SARS-Cov-2
is transmitted via HM [320–322]. While viral RNA has been isolated in some HM samples
of positive SARS-Cov-2 mothers, no samples contained replicant-capable SARS-Cov-2,
and thus infectious virus has not been found in milk [101,320,322–325]. Instead, there is
evidence that antibodies to SARS-Cov-2 isolated in HM have an immunological response
against the virus [326–328], with samples from infected mothers demonstrating strong
sIgA activity specific to SARS-CoV-2. When active SARS-CoV-2 has been added to HM
in the laboratory setting, holder pasteurisation (62.5 ◦C for 30 min) inactivates replicant-
capable SARS-CoV-2. As such PDHM, when pasteurized using the Holder technique, can
be considered as safe and feasible for use
Finally, with the global roll-out of vaccines against SARS-CoV-2, the accumulating
evidence has demonstrated that both pregnant and breastfeeding women secrete SARS-
CoV-2 specific IgA and IgG antibodies after vaccination [328–330] Furthermore, they had
similar responses to nonpregnant controls, with immune transfer occurring via the placenta
and HM. The current evidence indicates that pregnant and breastfeeding women should
continue to be routinely offered vaccination against SARS-CoV-2.
Overwhelming evidence supports breastfeeding throughout the COVID-19 pandemic;
however, the support enabling women to continue breastfeeding and the mental wellbeing
of pregnant and lactating women remains a significant concern. Our research in Australia
and New Zealand has demonstrated that during the COVID-19 pandemic, mental health
issues faced by breastfeeding women appear to be exacerbated by COVID-19. We found
greater health consequences noted for women who were pregnant for a longer duration
during the pandemic and living in regions with higher COVID-19 infection rates [331].
International research supports this notion, with unprecedented increased postpartum
anxiety and depression rates occurring during the pandemic amongst pregnant and lactat-
ing women [332–334]. While some breastfeeding mothers have noted the pandemic and
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lockdowns have resulted in less pressure and more family support at home to continue
breastfeeding [331,332,335–337], others have highlighted a reduction in access to support
has directly contributed to their early weaning [332]. More robust policies and actions that
enable mothers to access their immediate support networks and mental health services re-
main essential to protect women’s wellbeing and continued breastfeeding as the pandemic
continues.
31. Summary
In summary the understanding of breastfeeding and human lactation as a biological
system will provide a strong knowledge base from which to direct future research, devise
interventions to improve maternal and infant health as well as inform public policy with
respect to breastfeeding. New research methods will create the much-needed evidence to
underpin education and advocacy in this field. Indeed, human lactation science is critical
to the success of the global impetus to increase breastfeeding universally.
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